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Inflammation is a self-protective response in which the body tries to get rid of 
harmful stimuli including damaged cells or pathogens. Leukocytes circulating in the 
blood stream are stimulated by chemokines released by endothelial cells that enable 
them to adhere and transmigrate to the site of infection. Leukocyte extravasation 
from the blood vessels towards the site of inflammation is a sequential and 
overlapping process involving leukocyte rolling, adhesion and transendothelial 
migration. During inflammation, antigen-presenting cells (APCs) present antigen to 
the T cells by binding to the T cell receptor (TCR). Adhesion is critical for T-cell 
trafficking and antigen recognition and is mediated in part by integrins, a large 
family of αβ heterodimeric cell surface proteins. Integrins exist in at least three 
different conformations: bent, extended-closed and extended-opened. The β2-
integrin lymphocyte function-associated antigen-1 (LFA-1 /αLβ2) and the β1-
integrin very late antigen-4 (VLA-4/α4β1) promote T-cell interactions with their 
ligands intercellular and vascular cell adhesion molecules (ICAMs and VCAMs) 
respectively which are expressed on endothelial cells. VLA-4 and LFA-1 directly 
participate in cell arrest under flow, whereas firm adhesion is mediated by LFA-1.  
The cytoplasmic tails of integrins are short and lack catalytic activity. Several 
proteins, such as filamin, talin, 14-3-3, α-actinin and kindlin interact with the 
cytoplasmic part of the β2-chain. Some of these proteins–integrin interactions are 
in turn regulated by phosphorylation and dephosphorylation states of the β2-chain. 
As an adaptor protein, 14-3-3 is shown to interact with the phospho (p) Thr-758 of 
the β2-tail and activates Rac1, an actin–regulating protein. The first finding in this 
thesis was that in T cells, Tiam1 binds with 14-3-3 and is essential for Rac1 
activation and cell migration. Tiam1 is a Rac guanine nucleotide exchange factor 
(GEF). Upon LFA-1 activation via anti-CD3 against the TCR or via stromal cell-
derived factor 1α (SDF-1α), Tiam1 forms a complex with β2 phosphorylated on Thr-
758 and the scaffolding protein 14-3-3, which activates Rac1. Downregulation of 
Tiam1 inhibits Rac1 activation and furthermore, it impairs cell adhesion to the LFA-
1 ligand ICAM-1.  
Integrins have unique characteristics of signaling at both directions across 
the membranes. Inside-out signaling occurs by ligand binding to non-integrin 
receptors, which can activate integrins through intracellular signal transduction 
whereas outside-in signaling takes place by binding of ligands to the integrin itself. 
The next finding was that the activation of LFA-1 via inside-out or outside-in 
 
 
signaling downregulates VLA-4 binding to its ligand VCAM-1. When LFA-1 is 
activated upon SDF-1α, it causes the phosphorylation of Thr-758 on the β2-chain, 
which recruits 14-3-3 and Tiam1 and results in crosstalk to VLA-4. It leads to the 
dephosphorylation of Thr-788/789 on the β1-chain, which results in recruiting 
more filamin but less 14-3-3 to the β1-chain.  
Another finding of this thesis was that the activating and some inhibiting 
antibodies against LFA-1 binding to the extracellular part, block VLA-4 binding to 
its ligand VCAM-1. We identified that LFA-1-specific monoclonal antibodies that 
activate LFA-1 but inhibit VLA-4, inhibit both LFA-1 and VLA-4, inhibit LFA-1 but 
not VLA-4, and neither affect the activity of LFA-1 nor VLA-4. We found that 7E4, an 
antibody that blocks LFA-1 binding to ICAM-1, concurrently activates intracellular 
signaling resulting in the phosphorylation of Thr-758 of the β2-chain, which leads 
to crosstalk to the VLA-4, inhibiting its activity. The activation of LFA-1 was 
mediated through phospholipase C (PLC) and protein kinase C (PKC) activation, 
which causes the phosphorylation of the Thr-758 on the β2-chain. These findings 
are significant for understanding the effects of antibody treatment on integrins, i.e. 
how they regulate integrin functions, and thus also in the use of LFA-1-specific 
antibodies in clinical applications.  
In my fourth publication, I have also shown that the phosphorylation of the 
LFA-1 α-chain at Ser-1140 is essential for the functionally significant 
phosphorylation of the β-chain Thr-758 and protein interaction with the β2-chain. 
Mutation of Ser-1140 to alanine in the αL-chain significantly decreased Thr-758 
phosphorylation of β2-chain after SDF-1α or anti-CD3 activation. This αL mutation 
also affects the exposure of the LFA-1 activation epitope for ligand interaction. α-
Actinin is an actin-binding protein, which links integrins to the actin cytoskeleton 
and it is crucial for cell migration. We showed that mutation of Ser-1140 to alanine 
in the αL-chain affected the α-actinin interaction with the β2-chain and chemotactic 
directional migration. Phosphorylation and de-phosphorylation of αL- and β2- 
chains may be a way to regulate adhesion and deadhesion turnover of cells during 
migration. 
To summarize, the thesis has elucidated the importance of the 
phosphorylation of Thr-758 on the β2-chain and Ser-1140 on the αL-chain of LFA-
1. We have identified a new key molecule, Tiam1 in intracellular signaling 
downstream of LFA-1. We also have elucidated the crosstalk mechanisms of the 
activation of LFA-1 to VLA-4. We have revealed that the anti-LFA-1 activating or 
inhibiting antibodies crosstalk to VLA-4 as well. Finally, we have demonstrated that 
 
 
phosphorylation of the αL-chain on Ser-1140 is vital for β2-chain phosphorylation 
and protein-protein interactions.  
De-regulation of integrins’ function may lead to auto-immune and chronic 
inflammatory diseases. Here in this thesis, I have now revealed some novel, 
important mechanisms of the regulation of the leukocyte integrins. The knowledge 
of how integrins are regulated could be beneficial in clinical applications as well as 




IV. Review of the literature 
1. The immune response 
When the body is invaded by foreign particles, it reacts through a defense 
mechanism known as the immune system. In an immune reaction, several types of 
cells are activated to destroy foreign substances. Two fundamental immune 
response mechanisms have been described: the innate immune system in which 
cells encounter invaders immediately or within hours, and the adaptive immune 
system in which the initial interaction with pathogens result in an immunological 
memory that is specific to precise antigen. 
2. Leukocytes 
The immune mechanism is the body's defense mechanism involving a synchronized 
network of different organs, tissues, and cells. White blood cells come in two major 
types: myeloid and lymphocytes. These cells work together to seek and destroy any 
foreign molecules entered the body. Phagocytic cells in the innate immune system, 
such as macrophages, monocytes, and neutrophils, kill pathogens rapidly. The 
lymphocytes, T and B cells are the most critical cells in the adaptive immune 
responses. 
During inflammation, T cells recognize the antigens, which are presented by 
the antigen-presenting cells (APCs) and kill pathogens or impaired the cells. 
Pluripotent hematopoietic stem cells in the bone marrow develop into immune cells 
like T cells and B cells. T cells mature and differentiate in the thymus whereas B cells 
mature in the bone marrow (Ross, 1994). Before entering the thymic cortex, T cells 
go through a positive selection to check that the T cells can interact with major 
histocompatibility complex (MHC) molecules. If T cells can interact with the MHC 
molecules, they will receive a survival signal; however if they are unable to interact, 
they will get a non-survival signal, and will eventually die. The survived T cells that 
interacted with MHC I, differentiate into CD8 T cells, also called cytotoxic T (Tc) cells, 
while those that interacted with MHC II, become CD4 T cells, also called helper T (TH) 
cells. After T cells differentiate into CD8 or CD4 cells, they move to the thymic 
medulla where they undergo a negative selection. This selection examines how the 
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newly produced T cells will interact with the self -MHC molecules. If the interaction 
is strong, the cells will receive apoptotic signals. And if they somehow survive, T 
cells will induce autoimmune diseases. After the positive and negative selection 
stages, T cells will be released from the thymus as mature CD4/TH cells or mature 
CD8/TC single positive cells and circulate in the periphery. The function of the TC 
cells is to remove virus-infected cells and neoplastic cells. TH cells are capable of 
influencing a variety of immune cells and provide immediate response to cytokines, 
which is essential for an effective outcome against infection. Proliferating TH cells 
referred to as effector TH cells are divided into TH1 and TH2 cells; helper T cells which 
encounter interleukin-12 (IL-12) become TH1 and those influenced by IL-4 become 
TH2 cells (Cota & Midwinter 2015). 
A successful defense mechanism depends on the ability of the leukocytes to 
travel in the blood and lymph as non-adherent cells and to migrate as adherent cells 
into the lymph node and tissue in response to invaders. Lymphocytes, which are 
activated by dendritic cells (DCs) or APCs must be able to assemble in the lymphoid 
organs, cross endothelial membrane barriers and aggregate at the site of infection. 
The transition between the nonadherent and adherent phenotype is crucial for 
immune reaction and surveillance.  
Three main groups of adhesion receptors are involved in the processes of 
lymphocyte homing to different lymphoid organs and lymphocyte filtration to the 
site of inflammation. First, the immunoglobulin (Ig) superfamily, which contains 
among others the antigen-specific receptors for T and B lymphocytes; secondly the 
integrins, which are essential for the maintenance of cell adhesion and migration; 
and finally the selectins, which are important for lymphocyte interactions with the 
endothelium (Springer 1990). Too tight or continuous adhesion of cells with 
different receptors can cause chronic inflammation. Stringent regulation of 
lymphocyte adhesion from circulation to the site of inflammation is important for a 
fine-tuned immune system. 
2.1 The immune synapse 
Immune cells like T cells or natural killer (NK) cells communicate with the APCs 
through a close cell–cell interaction, which is known as the immune synapses (IS). 
Additionally, cytotoxic T cells or killer cells use the immune synapse to target the 
infected or malignant cells more specifically and eliminate them from the system, 
leaving the healthy cells unaffected (Dieckmann et al. 2016). Formation of the 
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immune synapse is vital for T-cell activation. Necessary physiognomies of a matured 
immune synapse include the transformation of peptide–MHC complexes from APCs 
to T cells and the control of secreted cytokine lytic granules (Davis & Dustin 2004). 
Successful formation of the immunological synapse requires TCR 
reorganization to recognize MHC peptides and adhesion via LFA-1 to form a 
functional domain at the edge of the two cells. The structure of the immunological 
synapse refers to the ‘bullseye’ model, which makes concentric rings of different 
clusters of proteins in various layers (Figure 1). The formation of the immunological 
synapse was first presented by Kupfer in 1995 in a ‘Keystone Symposium’ where he 
showed three-dimensional images of CD4 T cells targeting another cell (Monks et al. 
1998). Another name of the immune synapse is supramolecular activation cluster 
or SMAC. SMAC contains three unique rings: the central SMAC (cSMAC), peripheral 
SMAC (pSMAC) and distal SMAC (dSMAC). In the developed IS, TCR cluster in the 
central ring of the IS (cSMAC) with its co-receptor CD28, protein kinase C-θ (PKC) 
and lymphocyte-specific protein tyrosine kinase (Lck). Adhesion molecule LFA-1 
with its adaptor protein talin is usually found at the periphery of cSMAC called 
pSMAC, and actin, CD43, CD44 and CD45 in the dSMAC (Dieckmann et al. 2016).  
 
Figure 1: A. The molecular distribution of the immune synapse with the characteristic 
‘bullseye’ view cSMAC (central supramolecular activation cluster), pSMAC (peripheral 
SMAC), dSMAC (distal SMAC). B. A schematic drawing of the immunological synapse and the 
molecular dissemination between the T cells and the APC (antigen presenting cell). Modified 
from Huppa and Davis 2003. 
The TCR is a complex of antigen specific α and β chains associated with the 
CD3 γ, CD3 δ, CD3 ε and CD3 ζ chains. Each of CD3 chains has the common signaling 
motif called immunoreceptor tyrosine-based activation motif (ITAM) in the 
A B 
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cytoplasmic domain. T cell activation requires the interaction with other molecules 
such as CD45, a tyrosine phosphatase enzyme, and the T cell co-receptors, either 
CD4 or CD8. In the activation of CD4 co-receptor, quite a number of events take place 
after the MHCII complex with peptides binds to the TCR. CD45 dephosphorylates 
the terminal tyrosine of Lck and initiate its kinase activity. When CD4 interacts with 
the MHCII molecules, Lck phosphorylates the ITAM domains, and at this point, 
tyrosine kinase ZAP-70 (Chan et al. 1992) is recruited to the ITAM domain and binds 
through the SH2 domain. Then ZAP-70 is phosphorylated by Lck and able to 
phosphorylate transmembrane proteins with long intracytoplasmic domain LAT 
(linker activated of T cells). It binds to the adaptor protein Gads and recruits the 
cytoplasmic protein SLP-76 and forms a large scaffold (Chakraborty & Weiss 2014) 
(Figure 2). This scaffold then is used as a subsequent signaling pathway activator. 
Following events, including the activation of PLCγ, requires the contribution of 
another co-stimulatory pathway involving CD28. Furthermore, PLCγ generates 
second messenger inositol trisphosphate (IP3) and diacylglycerol (DAG) 
(Dieckmann et al. 2016). The cascades downstream of TCR activation ultimately 
result in cellular proliferation, differentiation and cytokine production. 
 
Figure 2: A simplified schematic picture of TCR (T cell receptor) activation. Description of 
the TRC activation is mentioned in the earlier paragraph.  
Recently, it has been found that the formation of the immune synapse helps 
to localize the cytotoxic substances in the T cells for killing the tumor or virally 
infected cells more specifically (Dieckmann et al. 2016). Another fascinating feature 
of the immunological synapse is to function as a platform to transfer cellular or 
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genetic molecules via extracellular vesicles between T cells and the APC (Finetti et 
al. 2017). It has been described that human lymphotropic viruses such as HIV-1 
ensures its spread and escaping from the host immune response by formation of the 
synapse. HIV-1 hijacks the diverged vesicular machinery from the host cells for 
assembly and focuses on producing new virions at the virological synapse (VS), 
which is a contact zone between the infected and uninfected CD4 T cells (Soares 
2014). There are structural similarities between IS and VS. Same regulators like 
EW1-2, α-actinin and TCR signaling components have been found in both VS and IS. 
Interestingly, engagement of TCR by pMHC (peptide-MHC) leads to the enrollment 
and the accumulation of gag (a genetic code for group specific antigen) for HIV-1 at 
the IS, and will result in budding of gag microvesicles. Afterward, vesicles secreted 
by HIV-1-infected cells will carry chemokine receptors (CXCR4) that facilitate 
entering the non-permissive cells (Finetti et al. 2017). HIV-1 then takes control of 
the assembly of the IS by impairing both the interaction of Lck with the TCR and also 
the association of LAT with the actin cytoskeleton (Silva et al. 2016). 
2.2 Leukocyte adhesion and migration 
In response to the infections, leukocytes must leave the blood vessels to get into the 
inflamed tissue. The journey of a leukocyte from the bloodstream into tissues is a 
highly organized and well-maintained process, which involves the multifaceted 
interaction between the leukocyte and the endothelium. In immunology, the process 
of the outward way of the immune cells through the integral vessel is known as 
leukocyte extravasation or diapedesis. The leukocyte interacts with the endothelial 
cells via selectins, integrins, intercellular adhesion molecules (ICAMs), vascular 
adhesion molecules (VCAM-1), junctional adhesion molecules (JAMs), and platelet 
endothelial cell adhesion molecules (PECAMs). In the human liver, VAP-1 (vascular 
adhesion protein-1) plays an important role as an adhesion receptor expressed by 
endothelium. Since sinusoidal endothelial cells lack selectin expression, VAP-1 is 
critical for lymphocyte adhesion and transmigration through the endothelial to the 
recruitment in the liver (Lalor et al. 2002). Extravasation is based on a sequential 
and overlapping process including leukocyte rolling, arrest, firm adhesion and 
transendothelial migration (Figure 3). This phenomenon was already described in 
the nineteenth century by Rudolf Wagner and Rudolf Virchow (Ley 2008). 
The first step of the leukocyte extravasation is the release of inflammatory 
cytokines and bacteria-derived peptides, which induce the upregulation of adhesion 
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molecules on the endothelial cells, further promoting labile and transient adhesion 
interactions (rolling) between leukocytes and the endothelial cells. Chemokine 
deposition on the endothelial luminal surface then triggers the integrin-mediated 
arrest via their ligands VCAM-1 and ICAM-1, and promote strong adhesion. After 
this firm adhesion, the cells start to transmigrate between or through the 
endothelial cells and reach the inflamed tissue in a process called diapedesis. The 
more detailed mechanisms are shown below. 
 
Figure 3: Essential steps of leukocyte extravasation and molecules involved in this process. 
Tethering of the leukocytes on the surface of activated endothelium occurrs through the 
interactions between E-selectin with its ligand ESL-1 and P-selectin with the ligand PGSL-1. 
Tethering and rolling precede firm adhesion, which is mediated by the interaction of VLA-4 
and LFA-1 with VCAM-1 and ICAM-1, respectively. 
2.2.1 Selectin-mediated adhesion 
The first step of extravasation is rolling of the leukocytes on the endothelial cells, 
which is mediated by selectins. Selectins have lectin N-terminal domains which 
initiate the transient adhesion of cells to their transmembrane glycoprotein and 
glycolipid ligands containing the tetrasaccharide sialyl-Lewis. This results in rolling 
on the endothelial cells (Homeister et al. 2001). Three selectins have been described: 
L-selectin, P-selectin, and E-selectin. L-selectins are mostly expressed on the 
leukocytes, while E-selectins are expressed on the activated endothelial cells and 
are induced by cytokines, like tumor necrosis factor (TNF) and interleukin-1 (IL-1) 
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(Bevilacqua et al. 1987). On the other hand, P-selectins are expressed both on the 
platelets and the endothelial cells by the influence of released histamine and 
thrombin (Homeister et al. 2013). The interaction between the selectins and the 
leukocytes is transient and it initiates the rolling of leukocytes along the endothelial 
in the direction of blood flow (Lawrence & Springer 1991). During the rolling steps, 
bonds are formed at the leading edge and released at the trailing edge of the cells. 
Initially, leukocyte integrins stay in a resting state, and immunoglobulins on the 
endothelial cells remain at basal levels. P-selectin is the essential selectin for rolling 
processes, but it can also support capture (McEver 2015). P-selectin glycoprotein 
ligand-1 (PSGL-1) is constitutively expressed in all lymphocytes and other 
leukocytes as well. L- and E–selectins also take part in the rolling steps. It was shown 
that in the absence of P-selectin, rolling became L-selectin dependent, but the rolling 
was much slower compared to the P-selectin-dependent rolling. L-selecting-
dependent rolling also requires the expression of E-selectin on the endothelial cells 
and CD18 integrins expression on the rolling leukocytes (Jung et al. 1998, Jung & 
Ley 1997). Even though E-selectin is less efficient for leukocyte rolling, it is 
necessary for the typical inflammatory response in capturing leukocytes and 
initiating rolling (McEver 2015).  
2.2.2 Integrin mediated adhesion and transmigration 
Integrins are as well involved in rolling and mediate firm leukocyte adhesion on 
endothelial cells. In the gut, α4β7 mediates rolling of the cells on endothelial via the 
interaction of mucosal vascular addressin cell-adhesion molecule-1 (MAdCAM-1) 
(Erle et al. 1994), and α4β1 (VLA-4) mediates rolling of the cells through the 
interaction with VCAM-1 (Berlin et al. 1995). The integrin is thought to be essential 
for monocytes and T cells is VLA-4, and VLA-4 interacts with its ligand VCAM-1, 
which is expressed widely on activated endothelial cells (Imai et al. 2010). The 
upregulation of integrin expression on the leukocytes and their ligand expression 
on the endothelial cells result in adhesion (Springer 1995, Zhou et al. 2005). It has 
been shown that lymphocyte rolling and adhesion in the venules of the central 
nervous system (CNS) is VLA-4 mediated independently of P-selectin engagement 
(Vajkoczy et al. 2001). In neutrophils, the rolling and capturing are mediated by the 
selectins and the interaction between LFA-1 and its ligands ICAM-1 and -2 on the 
endothelial cells (Springer 1990, Gahmberg et al. 1997). 
Chemokines that are secreted by the endothelial cells activate leukocyte 
adhesion. Chemokines bind to G-protein coupled receptors (GPCRs) on leukocytes, 
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facilitating the rapid intracellular signaling events that activate the β2 integrin for 
their interaction with the ICAM counter-receptors expressed on the endothelium. 
The interaction between the integrin and the ligands initiate a signaling cascade in 
the leukocytes, which cause further strengthening of the leukocyte–endothelium 
adhesion by changes in the actin cytoskeleton (Gahmberg et al. 1997, Hogg et al. 
2011b, Ley et al. 2007, Toivanen et al. 2008). In contrast to naive or memory 
lymphocytes, the effector cells do not need chemokine activation to be arrested on 
the endothelium. Instead, the effector lymphocytes express a vast number of 
activated leukocyte integrins on the surface that can be available for ligand 
interaction (Shulman et al. 2011, Lek et al. 2013). 
During crawling, leukocytes change their morphology drastically from round 
to flat and highly polarized, defining a cell ‘front’ and a ‘rear’ or ‘uropod (Filippi 
2016). This highly polarized leukocyte creates lateral movement through the 
formation of cell protrusions, lamellipodia, filopodia, and the invadosome to exit the 
endothelial cell layer. At the leading edge, lamellipodia go through an intensive 
dynamic actin cytoskeleton reorganization. Filopodia even extend further towards 
the direction of migration from the lamellipodia (Ley et al. 2007). In the lamellipodia, 
consistent formation of strong adhesions takes place that comprises integrins, talin, 
and other adhesion-associated molecules. The cell exploits stable adhesion sites 
while dragging the cell body along the surface. In the rear, adhesion sites are 
interrupted, and there is a turn-over of molecules that are then recycled to the 
leading edge of the cell (Ley et al. 2007). 
The leukocytes migrate through the endothelial layers by two separate routes: 
the paracellular (between the cells) and the transcellular (through the cells) route 
(Carman et al. 2007, Mamdouh et al. 2009). In the paracellular route of migration, 
the interaction between the activated endothelium and the leukocytes opens the 
inter-endothelial cell junctions and stimulate leukocyte migration through cell–cell 
junctions. The transcellular migration takes place by the secretion of chemokines 
from the intracellular endothelial stores, which facilitates the leukocyte to migrate 
through the endothelium (Shulman et al. 2012). In the migration process, cells use 
different kinds of adhesion molecules including integrins and proteases compared 
to the rolling or adhesion process on endothelium. 
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3. Leukocyte integrins 
Integrins are transmembrane cell adhesion proteins that link cell surface molecules 
of bound cells or the ECM to the cell cytoskeleton. They are composed of different 
α- and β- subunits which are type I membrane glycoproteins. They contain an 
extended extracellular part and usually a short cytoplasmic tail (Alberts et al. 1994). 
There are 18α, and 8β subunits identified in vertebrates, and these form 24 distinct 
α–β heterodimer receptors (Figure 4). The diversity of these subunits enables a 
large variety of ligand recognition, in binding to cytoskeletal components and 
coupling to downstream signaling pathways. In leukocytes, integrins play a crucial 
role in trafficking, migration, immunological synapses formation and phagocytosis 
(Luo et al. 2007). 
3.1 Leukocyte integrin classification 
In leukocytes, several integrins are expressed depending on the activation and 
maturation status and on the cells types. LFA-1, also known as αLβ2 or CD11a/CD18, 
macrophage antigen-1 (Mac-1, αMβ2 or CD11b/CD18), αXβ2 (CD11c/CD18) and 
very late antigen-4 (VLA-4, α4β1 or CD49d/CD29) are integrins expressed on 
leukocytes (Chigaev and Sklar 2012, Abram and Lowell 2009). α4β7 (Ruegg et al. 
1992) and αEβ7 (Andrew et al. 1996) are also expressed exclusively in leukocytes.  
 
Figure 4: The classification of integrins and their heterodimers. Integrins containing the 
inserted I domains for α-chains are indicated in red (α1, α2, α10, α11, αE, αD, αL, αM and αX). 
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3.1.1 LFA-1 (αLβ2, CD11a/CD18) 
LFA-1 is expressed on most leukocytes (Cornwell et al. 1993). In 1979, a child was 
diagnosed with defects in leukocyte migration and phagocytosis with recurrent 
infections. The reason behind these defects was found to be the lack of a gp150 
surface membrane glycoprotein complex (LeBien & Kersey 1980, Arnaout et al. 
1984). The glycoprotein was shown to make a heterodimer with to a 95kd 
glycoprotein (Beatty et al. 1984), and it was later named LFA-1. The LFA-1 belongs 
to the β2/ CD18 leukocyte differentiation antigen family that consists of p150/95 
glycoproteins (Davignon et al. 1981, Springer & Anderson 1986). In 1985, LFA-1 
was identified as an adhesion molecule using phorbol ester activation of T cells and 
adhesion to ICAM-1 using blocking antibodies (Patarroyo et al. 1985). LFA-1 binds 
to the members of the ICAM protein family (Patarroyo et al. 1987, Marlin & Springer 
1987, Staunton et al. 1989, de Fougerolles & Springer 1992, Tian et al. 1997). LFA-1 
also binds to JCAM (Ostermann et al. 2002), E-selectin (Kotovuori et al. 1993) and 
collagen (Garnotel et al. 1995a, Lahti et al. 2013). 
LFA-1 plays a crucial role in cell–cell interactions, in leukocyte adhesion to 
the endothelial cells during the extravasation, for T cell interaction with the APCs in 
the lymph node (Hogg et al. 2011), and cytotoxic T cell-mediated killing of infected 
cells (Davignon et al. 1981). In the immunological synapse, LFA-1 is necessary for 
the formation of sMAC strengthening (Monks et al. 1998). It has been shown that 
either an absolute or a functional loss of β2 integrins leads to the rare immune 
deficiency disease called leukocyte adhesion deficiency (LAD) type I (Anderson 
1987).  
3.1.2 VLA-4 (α4β1, CD49d/CD29) 
The VLA-4 is the CD49d (α4) and CD29 (β1) heterodimer and belongs to the β1 
integrin family, first discovered in 1987 in multiple T-lymphoblastoid cell lines 
(Hemler et al. 1987). VLA-4 is expressed in many cells, stem and progenitor cells, T 
and B cells, monocytes, NK cells, and eosinophils. VCAM -1 and fibronectin are 
ligands for VLA-4 (Elices et al. 1990, Guan & Hynes 1990). However, without 
activation, VLA-4 cannot interact with its ligands. Activation of VLA-4 goes through 
the different conformational changes to bind to the ligands. The α4-chain lacks an 
I–domain and easily become activated upon stimulation (Chigaev & Sklar 2012). 
VLA-4 is considered a critical adhesion molecule for maintaining 
hematopoiesis in the adult. It is reported that VLA-4 is not involved in the 
differentiation or proliferation of the hematopoietic cells, but instead, it is essential 
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for homing of hematopoietic cells in the bone marrow and helps for releasing the 
mature lymphocyte in the circulation (Imai et al. 2010). Antagonists of VLA-4 are 
shown to be clinically important in many inflammatory diseases (Chigaev et al. 
2011). Moreover, it is also shown that in multiple sclerosis, VLA-4 enables T cells to 
cross the blood-brain barrier (Lin & Castro 1998). 
3.2 Integrin structure and conformation 
The α and the β subunits of integrins comprise several domains in which each 
subunit contains a single membrane-spanning helix and a cytoplasmic part (Figure 
5A for the general structure of the integrins). Typically, the α- and β-subunits 
contain around 1000 and 750 amino acids respectively ( Luo et al. 2007, Campbell 
& Humphries 2011).  
 
Figure 5: A. A schematic drawing of the integrin α- and β- chains. B. Three different 
conformational stages of integrins. Bent (low affinity), extended (intermediate affinity), 
extended and open (high affinity). 
There are three different conformations of the extracellular part of the 
integrins: bent, extended but closed headpiece, extended and opened headpiece 
(Figure 5B). In the low-affinity state, the head of the integrins bends towards the 
plasma membrane. In the extended conformation, the two subunits closely associate 
with each other. This intermediate state of the integrins can have either low or 
intermediate affinity to the ligands. In the fully-active conformational stage of 
integrin, cytoplasmic domains of the α and β subunits are separated, and the ligand-
binding site is entirely open (Lefort & Ley 2012). 
A B 
IV. Review of the literature 
12 
3.2.1 The structure of integrin α-chains and the role of 
conformational change  
The α-chain of integrin contains 4–5 extracellular domains. All integrins have a 
seven-bladed β-propeller, a thigh, and two calf domains. Among all the integrins 
nine α-chain integrins contain inserted I-domains: α1, α2, α10, α11, αE, αD, αL, αM 
and αX. An inserted (I) αI domain or a von Willebrand factor A domain is composed 
of about 200 amino acids and the ligand-binding site resides in the αI-domain. The 
αI-domain is inserted between blades 2 and 3 of the β-propeller, and it has five β-
sheets surrounded by seven α-helices (Larson et al. 1989). On the other hand, in 
integrins lacking the I-domain, the interface (integrin head) between the α-subunit 
β-propeller domain and β-subunit βI-domain serves as the ligand-binding site 
(Springer & Dustin 2012). 
The αI-domain plays a vital role in ligand interaction and mutations in the αI-
domain alter the structure of the metal-ion-dependent adhesion site (MIDAS). The 
crystal structures of the I-domain of many integrins have been determined: αM 
(Bierema et al. 2017), αL (QU & Leahy 1995), α2 (Emsley et al. 1997), α1 (Salminen 
et al. 1999) and αX (Vorup-Jensen et al. 2003). MIDAS binds divalent metal cations 
(predominantly Mg2+) and plays critical roles in ligand binding. The switch from a 
closed, resting state to an active conformation in integrins leads to increased ligand 
affinity. The increased affinity for ICAM-1 due to a conformational change of 
integrins shows that the αI-domain is efficient in changing the conformation to 
change its affinity for ligand (Liddington & Ginsberg 2002, Luo et al. 2007).  
The C-terminal part of the α-subunit contains an immunoglobulin-like (Ig) 
“thigh,” two β-sandwich “calves,” a transmembrane domain and a cytoplasmic tail. 
The thigh and calf domains are rich in β-strands as compared to the typical Ig-like 
domains. One linker, between the β-propeller, the thigh and another linker, the 
“genu” or knee, is at the bend between the thigh and the calf-1 domain and provides 
inter-domain flexibility for the α-subunit (Figure 5A) ( Xiong et al. 2001, Gahmberg 
et al. 2009). 
3.2.2 The structure of the β-chains and the role of 
conformational change 
The β-chain contains a plexin–semaphorin–integrin (PSI) domain, a βI-like domain, 
an Ig-like hybrid domain, four epidermal growth factor-like (EGF) domains, a β-tail, 
a transmembrane domain (TM) and a cytoplasmic tail. The βI-domain, homologous 
to αI, is inserted in the hybrid domain, which in turn is inserted in the PSI domain to 
IV. Review of the literature 
13 
form the upper portion of the β-leg. The rest of the β-leg of the ectodomain is 
composed of four cysteine-rich regions of I-EGF domains and an α+β fold containing 
the β-tail domain (Campbell & Humphries 2011, Springer & Dustin 2012, Xiong et 
al. 2001). 
 
Figure 6: Inactive structure of Mac-1 I-domain (left). Active structure of the Mac-1 I-domain 
(right). When magnesium ions (black dots) activate Mac-1, the α7 helix (red) shifts position 
(Gahmberg et al. 2009). (Published with permission)  
The flexibility of the β-leg reported is based on the different crystallographic 
structures of the αXβ2 integrin (Xie et al. 2010). Plasticity of the EGF domains is seen 
between EGF-1 and EGF-2, the β- knee, and at the PSI/hybrid and hybrid/I-EGF1 
junctions. When the α7-helix of the βI domain moves toward the hybrid domain, a 
transition from a “closed” to an “open” conformation has been observed (Xia et al. 
2004). Inhibition of the allosteric communication between I-domains by small 
adhesion antagonist molecules that bind βI-domains demonstrates the importance 
of the close interaction between the αI- and the βI-like domain (Nishida et al. 2006). 
Allosteric regulation of the α-chain I-domain by the β-chain I-like domain is 
essential for regulating integrin conformation. βI-MIDAS activates the integrin αI-
domain, dragging the α7 helix by the interaction with the aspartic acid which is 
linked to the βI-domain from its resting position and the tail of the α and β subunit 
apart from each other. βI-MIDAS also utilizes glutamate (E310) as a ligand which is 
present in the linker formed by the α7 helix and the β-sheet 3 of the β2- propeller 
(Gahmberg et al. 2009) (Figure 6). It has also been shown that the Mg2+ ion at MIDAS 
interacts directly with the aspartic residue of RGD, which is the major binding site 
of many integrins (Gahmberg et al. 2009). The whole extracellular crystallographic 
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structures of αVβ3 (Xiong et al. 2001), αIIbβ3 (Zhu et al. 2008), αXβ2 (Xie et al. 2010) 
and α5β1 (Nagae et al. 2012) have been reported.  
3.2.3 The transmembrane domains 
Relatively little is known about the transmembrane regions of the α- and β-chains. 
The transmembrane domains (TMDs) of integrins are single spanning structures 
composed of approximately 24–30 amino acids, which form an α-helical coiled 
structure (Adair & Yeager 2002). The structures of the TM domains of αIIb and β3 
in phospholipid bicelle membranes have been solved by NMR separately (Lau, Dua, 
et al. 2008, Lau, Partridge, et al. 2008) and in a complex (Lau et al. 2009). It was 
shown that the αIIb-TM is a 24 residue α-helix that is perpendicular to the 
membrane whereas the β3-TM is a 30 residue linear α helix, The β3-TM domain is 
somehow longer than the width of a typical lipid bilayer suggesting that a helix tilt 
is present within the plasma membrane (Figure 7) (Campbell & Humphries 2011). 
The NMR structure shows that there are glycines (Gly) at the helix–helix interface 
of the αIIb in the membrane that makes a pair of phenylalanine residues (Phe) on 
the β3-TM part, which promotes electrostatic interactions between the aspartic acid 
(Asp-723) on β3 and arginine (Arg-995) on αIIb.  
 
Figure 7: A) NMR structure of the complex of the TMs (transmembrane domains) of the αIIb 
(blue) and β3 (red). Gray outlines show the membrane glycerol backbone. (B) Talin domains 
F2 in blue and F3 in yellow make a pair with a β-chain (red). The salt bridge forms between 
Lys-324 on F3 of talin and Asp-723 of β3-tail (Campbell & Humphries 2011). (Published with 
permission) 
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Figure 8: Sequence homologies of integrin TM (transmembrane) domains. The α and β-
subunits are packed through glucine–glycine (orange) interactions in the TM domain. The 
salt bridge is shown in green in the membrane-proximal site of the cytoplasmic region. The 
functionally important amino acid residues NPXY and NXXY are shown in red. 
Moreover, both the α and the β integrin TMDs possess 4–5 hydrophobic 
amino acids towards the C-terminal Lys residue in the transmembrane domains 
(Figure 8). The membrane-proximal region of α- subunits have a highly conserved 
Gly-Phe-Phe-Lys-Arg (GFFKR) motif, in which the two Phe residues are observed in 
all α-subunits regardless of species or integrin subtype. The conserved GFFKR 
sequence in the α-chains is significant for the non-adhesive state of integrins, while 
deletion or mutation of this motif results in integrin activation (O’Toole et al. 1994). 
3.2.4 The cytoplasmic tails 
The integrin cytoplasmic domains are short, mostly unstructured and comprised of 
10–70 amino acid residues except for the β4- subunit, which contains more than 
1,000 residues. The β-chain cytoplasmic tails are highly conserved while the α 
subunit tails are divergent (Figure 9). By studying the cytoplasmic peptides 
including the transmembrane/cytoplasmic interphase regions, it has been reported 
that the proximal portions of the α- and the β- cytoplasmic parts are α-helical and 
associate with each other (Iroumé et al. 2005). There are differences in published 
NMR studies of cytoplasmic tails. To date, only the structures of the αIIb/β3 
cytoplasmic tails have been characterized under heterodimeric conditions. X-ray 
crystallography, electron microscopy (EM) and cryo-EM structures reveal that in 
the inactive state of integrins, the cytoplasmic domains of α and β chains stay close. 
Association of either the α and β cytoplasmic domains or the α- and β- subunit 
membrane-proximal domain stalks results in integrin inactivation (Adair & Yeager 
2002, Lu et al. 2001). Also, Förster resonance energy transfer (FRET) -based studies 
provide evidence that separation of the cytoplasmic domains takes place after TCR 
activation of the integrins but not by ligand interaction (Wegener & Campbell 2008).  
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Figure 9: The cytoplasmic amino acids sequence of leukocyte integrin chains β1, β2, αL, αX, αM, 
αD, and α4. The amino acids which are important for phosphorylations are marked in red. 
4. Leukocyte integrin signaling  
Integrins transduce signals bidirectionally across the plasma membrane, referred to 
as “inside-out” and “outside-in’’ signaling. Each of these pathways is coupled to 
conformational changes in the integrin structures. Inside-out signaling is stimulated 
by chemokines or TCR activation that elicits the ligand-binding epitope, maintaining 
a higher-affinity state of the integrin ectodomain for its ligands. In contrast, outside-
in signaling triggers cellular responses upon ligand binding to integrins and is 
involved in integrin clustering, cell spreading, retraction, migration, and proliferation 
of the cells (Abram & Lowell 2009, Davis & Dustin 2004, Shen et al. 2012).  
4.1 Inside-out signaling 
Binding of ligands to non-integrin receptors on the plasma membrane initiate a 
series of intracellular signals, which leads to integrin conformational change and 
activation. Activation of the TCR, B cell receptor (BCR), chemokine receptor, and 
selectins may lead to inside-out activation of LFA-1 (Kinashi 2005). In T cells, LFA-
1-mediated adhesion can also be induced by CD3, CD2, CD44, CD45, CD73, CD98 and 
IL-2 receptors (Dustin & Springer 1989). 
The intracellular signaling cascades of leukocytes have already been discussed 
in connection with the formation of the immunological synapse and extravasation 
part in chapters 2.1 and 2.2. Even though the activation mechanisms may be similar 
among all leukocytes, variations also occur in different cell types or the status and 
maturation and expression of the integrins on the cells. As an example, during 
adhesion and extravasation, it has also been shown that the effector T cells are not 
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dependent on chemokine signaling, but in contrast, naive T cells are solely reliant on 
the chemokine activation for adhesion and transmigration (Shulman et al. 2012).  
In brief, ligation of TCR by anti-CD3 activates Lck, which in turn phosphorylates 
tyrosines in the ITAM motif of the CD3ζ chain. Activation of ITAM by phosphorylation 
further phosphorylates ZAP-70, and consequently, SLP-76 will be recruited to the 
phosphorylated LAT. The LAT/SLP-76 complex recruits and activates PLCγ. PLCγ 
hydrolyzes PIP2 into IP3 and DAG. IP3 induces the release of Ca2+ from intracellular 
stores into the cytoplasm by binding to IP3 receptors in the endoplasmic reticulum 
(Lewis 2001). DAG, in turn, activates PKC enzymes that phosphorylate Thr-758 in the 
β2-chain of the LFA-1 (Figure 10) (Fagerholm et al. 2005). 
 
Figure 10: A simplified scheme of inside-out signaling of integrins. After activation of TCR 
(T cell receptor), the protein tyrosine kinase Lck is phosphorylated and activated, leading to 
the phosphorylation of TCR. After that ZAP-70 is recruited to the TCR. ZAP-70 then 
phosphorylates LAT (linker for activation of T cells) and SLP-76 (leukocyte protein of 76 Kd). 
SLP-76 is a scaffold protein, associated with GEF (guanine-nucleotide exchange factor) like 
Vav1 and activates Rac1, and Arp2/3 (actin-related protein-2/3) complex. SLP-76 and some 
GTPases also interact with ADAP (adhesion and degranulation-promoting adaptor protein), 
and ADAP directly makes a complex with SKAP-55 (Src kinase-associated protein of 55Kd.). 
SKAP-55 binds and brings RapL to the membrane, resulting in interaction with LFA-1. The 
ZAP-70 and LAT/SLP-76 complex activates PLCγ and PLCγ hydrolyzes PIP2 to IP3 and DAG. 
DAG activates PKC, which phosphorylates β2-chain and activates integrins from bent to 
extended conformation to interact with the ligand and facilitates interaction with talin, 
kindlin and α-actinin. 
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The initial result from the inside-out activation of the integrin is the 
separation of the α- and the β-chains, which increase the ligand binding and 
promote strong adhesion. The conformation and activation of the integrin affect the 
interactions of the cytoplasmic proteins with the integrins. There are many studies 
using mutations in the integrins, which cause either constant activation of the 
integrin or inhibit ligand binding. X-ray crystallography and EM studies reveal 
regions or sites, which are necessary for β2 and β3 integrins’ activation (Luo et al. 
2007). The regulation of the inside-out signaling can be typical for the most of the 
integrins or specific for some integrins depending on the cellular situation. For 
example, αIIβ3-expressing CHO cells interact with an activation- recognizing 
antibody after treatment with phorbol 12-myristate 13-acetate (PMA) only if the 
cells express equal amounts of talin and PKCα (Han et al. 2006). The authors also 
found that Rap1 can activate αIIβ3 independent of PMA and PKCα stimulation (Han 
et al. 2006). Ligation of TCR activates PLC, which in turn triggers DAG and Ca2+ 
release and excite PKD. PKD relocalizes Rap1 to PKD1 (PKC effector protein D1) in 
the cell membrane and association with the β1 integrins (Medeiros et al. 2005). In 
CalDAG-GEFI knockout mouse, impairment of αIIβ3 activation and aggregation is 
seen (Crittenden et al. 2004). Neutrophils from such mice show defects in Rap1 
localization and consequently activation of β1 and β3 integrins. CalDAG-GEFI–null-
mouse resembles the defects of leukocyte adhesion deficiency type III (LAD III) 
disease where mutations are found in CalDAG-GEFI (Bergmeier et al. 2007). There 
is a signaling cascade describing the complex of talin and Rap1 effector protein, 
RIAM, which binds to the α-chain and activates the integrins αIIbβ3 and LFA-1 
(Watanabe et al. 2008, Zhang & Wang 2012 ). RIAM again links Rap1 to ADAP and 
Skap55, which are essential for αIIbβ3 and LFA-1 activation. In T cells, it was shown 
that the ADAP–Skap55 module makes a complex with Rap1–RapL after TCR 
activation. The interaction between RapL and the activated Rap1 brings RapL close 
to the cell membrane and allows RapL binding to the αL cytoplasmic chain of LFA-1 
(Zhang & Wang 2012). It has also been shown that the N-terminal domain of Skap55 
interacts with the C-terminal SARAH domain of RapL and forms a complex of 
Skap55-RapL-Rap1, which binds LFA-1 and increases binding to ICAM-1. In T cells, 
silencing of Skap55 impairs TCR-facilitated LFA-1 clustering and T cell–APC 
interaction (Jo et al. 2005). On the other hand, SDF-1α- or CCL21-induced regular 
migration is seen in Skap55-deficient T cells. It means that Skap55 is a specific 
adaptor protein that couples the TCR with the activation of Rap1–RapL component 
for LFA-1 adhesion. Skap55 knockout mice show deficiencies in β2 integrin 
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adhesion, clustering and downstream signaling (Wang et al. 2007). Thus, in T cells 
the Rap1/RIAM/ADAP/Skap55 complex formation at the membrane leads to talin 
activation and triggers integrin tail separation (Zhang & Wang 2012).  
4.2 Outside-in signaling 
Integrin outside-in signaling occurs through ligand interaction or integrin 
antibody binding (Campbell & Humphries 2011), or cation activation (Dransfield 
et al. 1992). Outside-in signaling may lead to firm cell adhesion, cell spreading, 
migration, and actin cytoskeletal rearrangement, even though all of these events 
depend on the types and conditions of the cell. For instance, in T cells, the outside-
in cascade is connected to cell proliferation, interleukin-2 (IL-2) production and 
establishment of the IS formation between the T cell and the APC. Alternatively, in 
neutrophils, the signal enhances the degranulation and activation of the NADPH 
oxidase enzyme and reactive oxygen species (ROS) production, which increase the 
cytotoxic efficacy of the cells. The outcomes of the outside-in signal in 
macrophages are the cell differentiation and control of the IL-1β mRNA 
production (Abram & Lowell 2009). 
There are two significant downstream consequences of outside-in signaling 
described (Figure 11). First, the formation of the focal adhesion (FA), a significant 
dynamic large protein assembly complex that spreads mechanical forces from 
sites of cell adhesion, and the reorganization of the actin cytoskeleton and integrin 
clustering . αIIbβ3 outside-in signaling occurs through tyrosine kinases 
particularly Src and Syk (Durrant et al. 2017). A lack of these kinases might affect 
both the signaling mechanisms of outside-in and inside-out of the integrins. In 
Jurkat cells, ligation of monoclonal antibodies to the β2 integrins leads to the 
clustering of integrins which then changes the focal zone of actin polymerization 
associated with other adaptor proteins and other downstream effector molecules 
in the outside-in signaling. Syk is capable of interacting directly both with the β3 
cytoplasmic tail and ITAM via an SH2 domain although the interaction with the 
ITAM motif is independent of the tyrosine phosphorylation of the β3 integrin 
(Durrant et al. 2017). The lack of Syk kinase blocks entirely the signaling events of 
β1, β2 and β3 integrins in neutrophils and macrophages (Mócsai et al. 2002). On 
the contrary, the absence of this kinase does not inhibit the GPCR signaling events 
in neutrophils or mast cells.  
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Figure 11: A simplified schematic path of outside-in signaling of integrins. Ligand binding to 
the integrin activates several kinases, including Src, FAK, and integrin-linked kinase (ILK). 
FAK binds to talin or paxillin, which interact with integrins. Phosphorylation of FAK, paxillin, 
and Src activates GTPase like WASP, also leading to Arp2/3 activation and actin 
polymerization. Ligand binding initiates the phosphorylation of SFK (Src family kinases) that 
phosphorylates ITAM, and activation of ITAM offers docking site for Syk (Syk family kinases) 
and ZAP-70. Downstream of signaling of SFK and Syk activates SLP-76 and ADAP. Ligand 
binding to integrins also phosphorylates cytohesin-1, and it is involved in ERK activation and 
IL-2 production. Ligand binding to LFA-1 releases JAB-1 (Jun-activating transcription factor) 
from its tail and transfer to the nucleus. In the nucleus, JAB-1 co-activates AP-1 (activator 
protein-1) resulting in IL-2 production. 
Some adaptor proteins also function as scaffold proteins involved in the 
outside-in signaling of integrins. Among them, SLP-76 is the best-studied one. 
Inhibition of SLP-76 in neutrophils, dendritic cells and platelets block outside-in 
signaling of β2 and β3 integrins (Bezman & Koretzky 2007). Another interesting 
finding of SLP-76 is that the mutations of Tyr to Phe in the N-terminal or mutated 
the Gads-binding regions interupt the SLP-76 interaction with Gads and 
subsequently impair the TCR signaling pathway (Abram & Lowell 2009). 
Furthermore, another adapter protein ADAP and its myeloid-specific homolog 
PRAM1 are also involved in outside-in and inside-out signaling.  
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Another protein named cytohesin-1 has been reported both in outside-in and 
inside-out signaling (Verma & Kelleher 2014). Blocking of this protein affects the 
LFA-1 mediated ERK activation and IL-2 production. The transcription factor, JAB-
1 (Jun-activating binding protein-1) is also involved in the outside-in signaling of 
LFA-1. When ligand binding activates LFA-1, JAB-1 is dissociated from the LFA-1’s 
cytoplasmic part and migrates to the nucleus and coactivates AP-1 and 
consequently facilitates IL-2 production (Perez et al. 2003).  
In outside-in signaling, the cytoskeleton is regulated through the modulation 
of RhoGTPases, which are governed by the Vav family of Rho-GEFs. Silencing or 
absence of Vav family proteins in neutrophils impairs β2-mediated adhesion, 
spreading of the cells and ROS production (Graham et al. 2007). In Vav1/3 knockout 
neutrophils, defects are also seen in β2-integrin mediated activation of Cdc42, Rac1, 
and RhoA. Vav proteins play significant roles in the regulation of PLCγ and Ca2+ 
signaling, predominantly in immunoreceptor (through TCR and BCR) pathways of T 
and B cells (Swat & Fujikawa 2005). Defects of PLCγ signaling and a poor Ca2+ 
response are seen in Vav knockout mice, and Vav signaling is also impaired in PLCγ 
knockout mice, as expected (Pearce et al. 2007). Other prime effectors of the 
cytoskeleton rearrangements in the integrin outside-in signaling pathways are 
RhoGTPases family members Rac, Rho, and Cdc42, which are vital for cell 
polarization and cell migration following adhesion (Ivetic & Ridley 2004). 
5. Regulation of leukocyte integrins  
Adhesion of leukocytes via integrins are pivotal mechanisms that convert 
biochemical signals to mechanical ones and vice versa or convey signals between 
cells. Regulation of integrins occurs at many levels. Integrins can be regulated 
through conformational changes, by integrin clustering and adhesion, and the 
timing of the interacting partners regulated by phosphorylation and adhesion 
maturation.  
5.1 Affinity and avidity regulation 
Integrin heterodimers undergo a process by which they change their conformation 
to increase the affinity of the ectodomains for extracellular ligand interaction 
(Iwamoto & Calderwood 2015). Crystallography and electron microscopic studies 
have described molecular mechanisms of integrin–ligand interactions and integrin 
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activation, and shown ectodomain extensions from bent to straight (Campbell & 
Humphries 2011, Gahmberg et al. 2009). However, the ectodomain rearrangements 
may vary between the heterodimers of different integrins (Xiong et al. 2009). Even 
so, most of the studies agree that the activation involves separation of the α- and β-
cytoplasmic tails and TMDs which can be elicited by talin and kindlin on the β-chain 
(Harburger & Calderwood 2009, Shattil et al. 2010). 
Inside-out activation of integrins transmitted from nonintegrin-mediated 
receptor would rapidly changes the conformation of the integrins and their affinity 
to bind the ligands. It has been shown by in vitro assays that this signal can be 
mimicked by adding divalent cations like Mn2+ (Smith et al. 1994), and 
Mg2+(Dransfield et al. 1992) or activating monoclonal antibodies (Luque et al. 
1996). 
Inside-out signaling pathways can also stimulate integrin clustering, which 
contributes to increased integrin avidity. It is unclear whether the same signaling 
pathways stimulate both the affinity and clustering of the integrins at the same time, 
although it is evident that specific stimuli like Mn2+ activate the adhesion of LFA-1 
but are unable to alter LFA-1 clustering (Kim et al. 2004). Research using T cells 
shows that upon PMA activation LFA-1 becomes more mobile in the lipid bilayer 
and clusters in the rafts (Krauss & Altevogt 1999). Interruption of lipid rafts inhibits 
leukocyte adhesion (Shen et al. 2012). However, in platelets lipid rafts do not 
influence the αIIβ3-mediated adhesion in outside-in signaling, but treatment of 
neutrophils with methyl-β-cyclodextrin (a chelating agent that disrupts the lipid 
rafts) induces integrin-mediated cell adhesion (Solomkin et al. 2007). Furthermore, 
crosslinking antibodies to the raft-associated CD24 increase LFA-1 clustering on the 
lipid rafts and also increase adhesion for ICAM-1, and this signaling is 
phosphatidylinositol-3-kinase (PI3K)-dependent. Additionally, exhaustion of 
cholesterol in the rafts prevents antibody- or PMA-mediated LFA-1 ligand binding, 
but will not affect the extracellular cation (Mg2+, Mn2+)-mediated ligand 
communication (Marwali et al. 2003).  
Leukocytes in the blood flow encounter shear force, which activates integrins; 
mechanical force can alter the conformation from bent to extended (Katsumi et al. 
2005) as well as the integrin clustering (Katagiri et al. 2006). Neither LFA- nor VLA-
4-mediated adhesion is seen in the absence of shear-pressure in the lymph node 
(Woolf et al. 2007). 
It has also been suggested that the conformational change of the integrins by 
inside-out activation is transduced by the β-chain, whereas the outside-in signaling 
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initiates the integrin clustering carried through the α-chain (Kliche et al. 2012). 
However, a mutation in the β-chain of triple Thr-(758–760) to Ala-(758–760) did 
not change the initial interaction with the ligand, but on the other hand there was 
no adhesion between the integrin and the ligand ICAM-1 (Morrison et al. 2013). 
5.2 Regulation through phosphorylation 
Phosphorylation reported for integrins is an important mechanism for the 
regulation of protein-protein interactions. Both inside-out and outside-in activation 
of integrins can be regulated by the phosphorylation of integrins (Gahmberg et al. 
2009). The cytoplasmic tails of the integrin are short but contain many potential 
protein binding sites. However, all proteins are not able to bind at the same time, so 
phosphorylation is one of the factors that regulate protein-protein interactions. It 
was reported already over two decades ago that the α-chains (αL,αM, and αX) of the 
β2 integrins are phosphorylated constitutively and the β2-chain upon cell activation 
(Gahmberg et al. 2009). 
5.2.1 Phosphorylation sites in β2 integrins 
There are several phosphorylations sites in the β2-chain. Tyr-735 in the β2-chain is 
found to be phosphorylated after IL-2 treatment of NK cells (Umehara et al. 1993) 
and during adhesion to type I collagen in neutrophils (Garnotel et al. 1995). This 
phosphorylation is vital for the LFA-1 internalization in the migration of T cells 
(Tohyama et al. 2003). The triple threonine on the β-chain (Thr-758–760) has been 
reported to be essential for the function of the leukocyte integrins (Hibbs et al. 
1991). Later studies have shown that phosphorylation is vital for LFA-1-mediated 
ICAM-1 adhesion. However, these phosphorylations are very transient and without 
okadaic acid (phosphatase inhibitor) easily missed (Valmu & Gahmberg 1995). It 
has been shown that after the treatment of T cells with phorbol ester, the Thr-758–
760 tripeptide on the β2-chain becomes phosphorylated and more detailed studies 
showed that Thr-758 is the major phosphorylated residue after TCR activation 
(Valmu et al. 1999, Hilden et al. 2003).  
Two serine phosphorylations sites Ser-756 and Ser-745 are known in β2-
chain (Fagerholm, Morrice, et al. 2002b, Hibbs et al. 1991). In T cells, Ser-756 
becomes phosphorylated after PMA treatment but not upon CD3 ligation, and it is 
not significant for ICAM-1-mediated integrin adhesion (Fagerholm et al. 2002). 
However, phosphorylation of Ser-756 is vital for Mac-1-dependent phagocytosis 
through Rap1 and talin interaction with the β2 integrins (Lim et al. 2011). In T cells, 
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Ser-745 becomes phosphorylated after the PMA treatment. The function for this 
phosphorylation is that it releases JAB-1 from LFA-1 and transfers it to the nucleus 
where it co-activates the c-Jun transcription factor, AP-1 resulting in ERK1/2 
signaling (Perez et al. 2003).  
There are many PKC members involved in the phosphorylation of the Ser and 
Thr amino acids. Mainly PKCδ and PKCβI/II phosphorylate Ser-745 and Thr-758 but 
also PKCα, and PKCη may phosphorylate these amino acids. The PKCα isoform is 
also able to phosphorylate the Thr-760. PKC families cannot directly phosphorylate 
the Ser-756. Nevertheless, Ser-756 gets phosphorylated upon phorbol ester 
activation, demonstrating that PKC may be indirectly involved (Fagerholm et al. 
2002).  
The phosphorylation site on the αL-chain is Ser-1140, and this 
phosphorylation is needed for the activation epitope expression and as well as for 
ligand interaction (Fagerholm et al. 2005). In Jurkat cells, the mutation of Ser-1140 
to Ala on the αL-chain of LFA-1 was unable to be activated by treatment with SDF-
1α-, the ligand ICAM-2 or Mg2+ (Fagerholm et al. 2005). However, phorbol esters 
and anti-CD3 could activate Jurkat cells containing the mutated LFA-1 for ligand 
binding (Gahmberg et al. 2014). It has also been shown that SDF-1α- or ICAM-2-
activated Jurkat cells containing the Ser mutation of LFA-1 cannot adopt the high-
affinity conformation detected with a mab24 antibody, which recognizes the openly 
extended conformation (Fagerholm et al. 2005).  
In Mac-1, the phosphorylation site for αM is Ser-1126, and it is constitutively 
phosphorylated like αL Ser-1140. Mutation of Ser-1126 to Ala affected ICAM-
1/ICAM-2 binding after phorbol esters or after extracellular Mg2+ treatment, but on 
the other hand binding to other ligands such as iC3b and denatured serum albumin 
(BSA) was not reduced (Fagerholm et al. 2006). Importantly, in vivo, homing of 
lymphocytes are also affected in the cells where αM contains the mutation. 
Attenuation of the phosphorylation of αM made cells stay in the circulation whereas 
WT cells accumulated in the spleen and lungs (Fagerholm et al. 2006). In αX, the 
phosphorylation site is Ser-1158. This phosphorylation is essential for adhesion and 
phagocytosis (Uotila et al. 2013). Phosphorylation sites for the αD-chain have not 
been reported yet. 
As mentioned earlier, phosphorylations of the amino acid residues in the 
integrin directly or indirectly influence the protein–protein interactions. 
Phosphorylation of Thr-758 directly guides the 14-3-3 and filamin interaction with 
the β2-cytoplasmic tail. It is shown that upon phosphorylation of Thr-758 filamin 
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detaches and simultaneously more 14-3-3 binds to the β2-chain (Takala et al. 2008). 
The phosphorylations of αL, αM, and αX are functionally important but which 
kinases phosphorylate them or how these phosphorylation affect the interaction of 
the protein are not fully elucidated.  
5.2.2 Phosphorylation sites in α4β1 and other integrins 
The phosphorylation of amino acid residues Tyr-783, Tyr-795, Ser-785, Thr-788 
and Thr-789 in the β1-chain have been described. Most of the studies use point 
mutations to clarify the importance of tyrosine for the cellular function. The tyrosine 
amino acids in the chain may be phosphorylated, but mutation of tyrosine to 
phenylalanine does not seem to affect integrin functions (Wennerberg et al. 1998). 
In contrast, phosphorylation of serine in the β1 shows the importance for integrins’ 
localization in the focal adhesion sites. Phosphorylation of Ser thus increased cell 
adhesion and concurrently inhibited cell spreading and migration (Mulrooney et al. 
2001). Threonine 788/789 residues of the β1-chain correspond to the 
phosphorylation site of Thr-758–760 of the β2-chain. The phosphorylation of these 
threonines in the β1 integrins is necessary for the activation epitope expression and 
fibronectin (Fn) binding (Wennerberg et al. 1998). Mutation of Thr to Asp acid on 
788, which mimics the negative charge of a phosphate group, makes the β1 integrin 
constitutively active and increased cell adhesion of GD25 (fibroblast) cells (Nilsson 
et al. 2006). Furthermore, it has been shown that extracellular pressure induces 
phosphorylation of Thr-788/789, which increases β1 affinity towards collagen, 
laminin, and Fn, although mutation of threonine to aspartic acid in these sites did 
not increase the adhesion over the basal level (Craig et al. 2009). 
Two phosphorylation sites of the α4 of VLA-4, Ser-988 and Ser-978, have been 
reported. It was shown that PKA phosphorylates Ser-988, and this is vital for paxillin 
interaction with the α-chain and VLA-4 function (Lim et al. 2008). Mutation of Ser-
988 to Ala of α4 integrin reduced cell spreading, migration, and mutation to Asp 
induced cell spreading but inhibited migration. In contrast, both mutations can 
mediate cell adhesion to VCAM-1. Thus both phosphorylation and de-
phosphorylation of Ser-988 are functionally important (Han et al. 2003). So, it seems 
that both wt and Ser-988 to Ala mutations can undergo outside-in signaling via 
VCAM-1 binding, while Ser-988 to Asp is not activated by ligand binding (Han et al. 
2001, Han et al. 2003). 
For leukocyte recruitment to the site of inflammation, paxillin interaction 
with the α4 integrin is needed (Alon et al. 1995). In the migratory cells, 
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phosphorylation of α4 enables integrin to be localized to the leading edge and 
mutation of Ser to Ala in the α4-chain destroyed lamellipodia formation and integrin 
localization. In contrast, there was no change in ligand affinity. Another interesting 
observation was that Ser-988 mutation to Asp acid in the α4-chain changed its 
localization; it was no longer enriched in lamellipodia (Goldfinger et al. 2003). 
Phosphorylation of Ser-978 was essential for 14-3-3 ζ interaction with VLA-4 and 
formed a complex of α4/14-3-3/paxillin that was needed for the activation of Rho-
GTPase and cell migration (Deakin et al. 2009). 
Phosphorylation of Tyr-759 of β3 integrins showed a vital role in signaling 
and platelet aggregation. Phosphorylation of Tyr-759 in β3 made the polypeptides 
resistant to calpain cleavage and inhibited integrin signaling, which is essential for 
cell spreading and focal adhesion formation (Phillips et al. 1999, Stojanovic et al. 
2006).  
6. Proteins involved in the signaling of β2 integrins 
Integrins inside-out and outside-in signaling are regulated by phosphorylation of 
the α- and β-chains and by cytoplasmic protein interactions with the tail of the 
integrins. Many studies show that the competition and the phosphorylations are 
important mechanisms to regulate the interactions of cytoplasmic proteins with the 
integrin tails (Gahmberg et al. 2009).  
6.1 Talin 
Talin is a cytoskeletal protein and one of the interacting proteins that links the 
cytoplasmic domains of integrins to the actin cytoskeleton (Hemmings et al. 1996). 
In vertebrates there are two talin genes encoding isoforms talin 1 and talin 2. Talin 
1 is ubiquitously expressed in mammals, on the other hand, talin 2 expression is 
limited with high levels in the heart, brain, and skeletal muscle (Monkley et al. 
2001). Talin is 270 kDa in size and contains a globular head domain around 50 kDa 
in the N-terminal and a more extended C-terminal tail domain, which is around 220 
kDa. The globular head domain has four FERM (FERM is protein 4.1, ezrin, radixin 
and moesin domain) subdomains and a C-terminal rod part that contains actin and 
vinculin binding sites (Hogg et al. 2011a). Talin is a crucial player in the activation 
of β1, β2, and β3 integrins and is pivotal for inside-out integrin signaling (Shattil et 
al. 2010). The FERM domain has three subdomains: F1, F2, and F3. The F3 
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subdomain interacts with the integrin membrane proximal NPXY/F region of the β-
chain via the phosphotyrosine binding (PTB) site (Madejón et al. 2012). 
An NMR study has shown that the Kd value of the talin head for the β2-tail is 
0.1–0.5 nM while the Kd αL for β2 is 2.6 nM meaning that talin head can disrupt the 
αβ heterodimer (Bhunia et al. 2009). Additionally, it has also been shown that the 
head domain of talin is involved in the separation of the αβ tails and the stabilization 
of the high-affinity conformation of αIIbβ3 integrin (Iroumé et al. 2005). It is known 
that talin binds to the integrin tail and triggers integrin activation but how talin 
binding to the tail is regulated is still not clear (Calderwood et al. 2013). A study 
shows the involvement of the Rap1 effector RIAM in talin-mediated αIIbβ3 
activation (Han et al. 2006). RIAM bound to the talin rod, and the RIAM–talin 
complex was recruited to the membrane with the active Rap1 (Lee et al. 2013). Later 
it has been shown that the RIAM-talin complex is needed for the activation of LFA-
1 but not necessarily for β1 and β3 integrin activation (Calderwood 2015). In the 
studies where researchers show that RIAM knockout mice are fertile and viable, 
platelets also aggregated normally, but there were severe defects in β2 integrin-
mediated leukocyte adhesion and trafficking (Su et al. 2015, Klapproth et al. 2015). 
Talin plays a vital role also in leukocyte regulation. Knockdown of talin by siRNA in 
both Jurkat and primary T cells showed a defect in adhesion to ICAM-1, decrease of 
LFA-1 clustering at the synapse, and impaired T cell-APC interactions (Verma & 
Kelleher 2014).  
6.2 Kindlin 
Many studies show that kindlin family proteins cooperate with talin (Calderwood et 
al. 2013). Kindlin contains FERM domains that are shown to interact with the distal 
NPXY motif, different from the talin binding site of the β1 and β3 integrin (Abram & 
Lowell 2009). Three kindlins are known: kindlin-1, -2 and -3 (Ussar et al. 2006). In 
Kindler syndrome, there is a mutation found in the gene encoding kindlin-1 protein 
(Karakose et al. 2010). The syndrome causes skin blistering and occurs due to the 
failure of actin function in keratinocytes. Kindlin-2 is ubiquitously expressed and 
interacts with ILK and migfilin (Montanez et al. 2008). Inhibition of kindlin-2 
prevents integrin activation, whereas co-expression of kindlin-2 and talin activates 
integrins. Overexpression of the talin FERM domain is sufficient to activate the 
αIIbβ3 integrin, whereas overexpression of kindlin-2 does not change integrin 
activation (Montanez et al. 2008). Interaction of LFA-1 with ICAM-1 induces integrin 
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clustering on T cells which in its turn induces association of kindlin-3 with the 
scaffold protein RACK1 (receptor for activated C kinase 1). This association 
activates the PKC enzymes and translocates the PKCs to different sites in the cells 
(Feng et al. 2012). ICAM-1 ligation to LFA-1 activates T cells and makes a ternary 
complex of β2-tail/RACK1/kindlin-3, which further activates LFA-1 (Verma & 
Kelleher 2014). 
6.3 Filamin 
Filamin is a large cytoskeletal protein that binds to the integrin β-chain. Filamin 
mediates the interaction between integrin cytoplasmic tails to F-actin. The binding 
site for filamin is localized in the C-terminal portion of the β- tail and partially 
overlaps with that of talin. Filamin appears to be a negative regulator of at least the 
β7 and β2 integrins by competing with talin for the β-integrin tail (Calderwood et 
al. 2001). Filamin has an N-terminal domain that binds to actin and a C-terminal 
domain composed of 24 tandem immunoglobulin-like domains, responsible for 
protein-protein interactions (Himmel et al. 2003). Filamin also binds to other 
receptors and molecules that affect the actin cytoskeleton, such as the small GTPases 
RhoA, Rac1, and Cdc42 (Ohta et al. 1999). The structure of the integrin-IgFLN21 
(filamin immuno- globulin-like domain (IgFLN) 21) complex has been resolved, and 
the crystal structure shows a general model for the filamin–integrin β7 interaction 
(Kiema et al. 2006). Phosphorylation of Thr-758 in the β2-tail inhibited filamin 
binding and at the same time recruited more 14-3-3 (Takala et al. 2008). Filamin 
plays a significant role in the regulation of cell motility, migration, and integrin 
signaling. It has been suggested that mutation or lack of filamin could be the cause 
of disorders in human. Mutation in the filamin A gene causes X-chromosome-linked 
brain disorders, in which neuronal migration is impaired during fetal development 
(Zhou et al. 2010). In melanocytes, loss of filamin causes impairment in migration 
and changes cell morphology (Liu et al. 2000). 
 
Figure 12: Amino acid sequence of the β2-chain with the known phosphorylation sites in 
red and the binding site for talin, α-actinin, 14-3-3,kindlin and filamin in blue. 
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6.4 α-actinin 
α-actinin is an antiparallel homodimeric rod-like and actin-cross-linking protein, 
which is expressed in all cells. In leukocytes, α-actinin plays a significant role in 
crosslinking the actin cytoskeleton with integrins (Gitlin & Colonna 2007). There 
are four isoforms of α-actinin called α-actinin 1-4. α-actinin 2 and α-actinin 3 are 
found in muscle cells whereas α-actinin 1 and α-actinin 4 are the non-muscle 
isoforms that are expressed in leukocytes. In leukocytes, α-actinins play a significant 
role in crosslinking integrins with the actin cytoskeleton (Otey & Carpen 2004, Foley 
& Young 2014). α-actinin is approximately 100 kDa and it contains three main parts: 
an N-terminal actin-binding domain, a central region of four spectrin-like repeats 
and a C-terminal domain containing two calcium-binding EF-hands (Virel & 
Backman 2004). The membrane-proximal region (aa 736–746) of the β2 integrin 
polypeptide contains the binding site for α-actinin, whereas the membrane-distal 
portion of β2-integrins has an inhibitory effect on binding to α-actinin (Sampath et 
al. 1998). It has been demonstrated that upon talin binding to the integrin, the α-
actinin binding site is exposed due to tail displacement in a membrane-proximal 
region of the tail, which may stabilize the integrin open conformation and allow firm 
adhesion (Hyduk et al. 2011). Phospholipids and calcium can also regulate α-actinin 
interactions. α-Actinin may be involved in the regulation of cell–matrix adhesion 
disassembly in motile cells. Furthermore, α-actinin interacts with intermediate 
affinity with LFA-1 at the leading edge, and thus controls T cell migration (Stanley 
et al. 2008). 
 
Figure 13: Schematic picture of the α-actinin protein. Each monomer contains an N-terminal 
actin-binding domain (ABD), a rod domain and a calmodulin (CaM)-like domain. ABD 
contains two calpain homology domains (CH1 and CH2), the rod domain comprise four 
spectrin repeats (SRs), and the CaM-like domain has two EF motifs. 
Using light scattering, it was shown that filamin and α-actinin bind weakly to 
the β-chain compared to the talin interaction (Goldmann 2000). α-actinin localizes 
with the integrin in the focal adhesions similar to talin in fibroblasts (Otey et al. 
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1990). α-actinin is also present along stress fibers. In fibroblasts and osteoblasts, 
integrin-binding fragments of α-actinin interrupt stress fibers, the formation of focal 
adhesions and shear-induced mechanical force signaling of cells (Pavalko & 
Burridge 1991, Pavalko et al. 1998). Mutations in the membrane-proximal site of 
the integrin tails also change focal adhesion formation and alter stress fibers (Liu et 
al. 2000). 
6.5 14-3-3 
The 14-3-3 proteins are small dimeric adapter proteins of 28–33 kDa that bind to 
phosphorylated Ser/Thr sequences in proteins altering their localization and 
activity. The association of 14-3-3 with the Thr-758-phosphorylated β2 chain is 
crucial for actin cytoskeleton rearrangements, cell spreading and adhesion to ICAM-
1 (Gahmberg et al. 2009). The 14-3-3 proteins are highly conserved from plants to 
mammals, and seven known mammalian isoforms of 14-3-3 have been identified. 
Although it has been shown that 14-3-3 can bind to the non-phosphorylated β2 
chain (Grönholm et al. 2011), 14-3-3 binds stronger to the phosphorylated chain 
(Fagerholm et al. 2005). Most of the ligands of 14-3-3 contain a specific sequence 
(RSXpS/TXP) which allows optimal binding. The interaction between 14-3-3 and 
integrin β2 is functionally significant since a mutation in Thr-758 to Ala of β2 chain 
abrogates actin cytoskeleton rearrangements, cell spreading, and adhesion to ICAM 
ligands (Fagerholm et al., 2005; Takala et al., 2008). 
6.6 T-lymphoma invasion and metastasis (Tiam1) 
Tiam1 is a Rac GEF (Guanine nucleotide exchange factor) protein and GEF proteins 
activate monomeric GTPases by stimulating the release of GDP (guanosine 
diphosphate) to allow binding of GTP (guanosine triphosphate) (Cherfils & 
Zeghouf 2013). Tiam1 is mainly present in the cytoplasm of cells; however, upon 
activation, Tiam1 translocates to the plasma membrane. Under normal cellular 
conditions, the concentration of GTP is higher than that of GDP, favoring the 
replacement of GDP by GTPases. As a GEF for Rac, Tiam1 is impotant for cell 
adhesion, migration, invasion, metastasis, and carcinogenesis (Minard et al. 2004). 
Initially, Tiam1 was identified as a gene that confers an invasive and metastatic 
phenotype to the murine T-lymphoma cells and activates Rho-like GTPase 
(Mohammed et al. 2014). 
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Tiam1 is significant for cell migration. Overexpression of Tiam1 abrogates 
migration and invasion of epithelial cells by stimulating E-cadherin-mediated cell-
cell adhesion between renal carsinoma cells. In contrast to this finding, Tiam1 may 
also stimulate cell migration and invasion of epithelial cells. Thus, it seems that the 
effects of Tiam1 on invasion to some extent is dependent on cell type and the levels 
of Rho and Rac (Ellenbroek & Collard 2007). Tiam1 has also been found in the 
progression of malignant tumor either as a mediator of Ras signaling in skin tumors 
or as a suppressor of the Wnt-responsive genes (Engers et al. 2006). Furthermore, 
overexpression of Tiam1 changes neuroblastoma and breast cancer cell 
morphology and cells become flattened epithelioid or sickle-shaped with extensive 
membrane ruffled (Minard et al. 2004). 
 
Figure 14: Tiam1 protein domain structure. Myc, myristoylation site; P, PEST sequence; PHN, 
N-terminal pleckstrin homology; CC, coiled-coil area; Ex, extended assembly; RBD, Ras-
binding area; PDZ- PSD-95/DlgA/ZO-1 domain; DH: Dbl homology domain; PHC: C-terminal 
Pleckstrin homology domain. 
Tiam1 interacts through its N terminus with 14-3-3 in HeLa cells and 
transfected COS7 cells (Woodcock et al. 2009, Pozuelo Rubio et al. 2004). It has also 
been shown that β1 recruits Tiam1 by 14-3-3ζ and subsequently facilitates Rac1 
activation (O’Toole et al. 2011). Tiam1 is also involved in T cell trafficking and 
transendothelial migration. It was shown that although PKCζ/Tiam1/Rac signaling 
is not essential for T cell arrest, this signaling is significant for the stabilization of 
polarization and efficient crawling of T cells on endothelium (Gérard et al. 2009). 
Tiam1 plays an essential role for chemokine receptor (CXCR4) and Rac activation 
and cell migration. Knockout of Tiam1 in T cells reduces chemotactic migration 
(Gérard et al. 2009).  
6.7 RapL 
RapL was found in a yeast two-hybrid screen as a Rap1 binding protein 
(Katagiri et al. 2003). Rap1 is also known as Ras-related protein 1. It is a small 
cytosolic GTPase. RapL consists of an N-terminal Ras–Rap binding domain and a C-
terminal coiled-coil domain, which are required for the direct or indirect interaction 
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with αL subunits (Cantor et al. 2008). Upon TCR or chemokine stimulation, RAPL 
binds to GTP-bound Rap1 and is essential for Rap1-mediated redistribution and 
clustering of LFA-1 (Hogg 2003). RAPL co-localizes with LFA-1 at the leading edge 
of migrating cells. Due to the proximity of a site consisting of two lysine residues 
following the GFFKR sequence in the αL cytoplasmic domain, it is proposed that, like 
talin, RAPL functions by destabilizing the αβ-cytoplasmic tail (Katagiri et al. 2003). 
RIAM-mediated binding of talin to the integrin β-tail and RAPL’s interaction with 
the kinase Mst1 promote LFA-1 clustering and integrin activation (Tadokoro et al. 
2003). Rap1/RAPL-mediated LFA-1 activation is regulated through the lysines-
1097 and 1099 (Cantor et al. 2008). It has also been reported that for VLA-4-
mediated T cell adhesion to VCAM-1, RapL interaction is essential for potent CCL25 
chemokine triggering (Parmo-Cabañas et al. 2007). Lymphocytes and dendritic cells 
of RAPL-deficient mice show reduced adhesion in response to chemokines, and 
homing and migration defects in vivo (Katagiri et al. 2004).  
7. Crosstalk between leukocyte integrins  
7.1 Crosstalk between β2 and β1 integrins 
A crosstalk between integrins means that the activation of one integrin regulates 
the function of other integrins. More than two decades ago, van Kooyk first noticed 
that in naive T cells and different T cell lines there are variations in LFA-1- and VLA-
4-mediated cell adhesion on activated endothelium. She found that naive T cells use 
both LFA-1 and VLA-4 for adhesion on endothelial cells, and as the cells further 
proliferate, the adhesion becomes dependent on LFA-1 rather than on VLA-4. She 
also explained that the cells adhere via VLA-4 only when LFA-1 is not activated (van 
Kooyk et al. 1993). Later on, it was shown that the activation of LFA-1 inhibits most 
VLA-4 molecules and to some extent VLA-5 binding to their ligands VCAM-1 and 
fibronectin (Porter & Hogg 1997). However, elimination of the I-domain from the 
αL-chain of LFA-1 shows a different outcome of increased VLA-4/VLA-5-mediated 
adhesion to VCAM-1 in Jurkat cells. It shows that the lack of the I-domain in LFA-1 
induces LFA-1 to be constitutively active and also activates VLA-4 and VLA-5, which 
consequently increases the VCAM-1 ligand binding. The increase of the VCAM-1 
ligand binding may be due to the VLA-4 clustering on the membrane that undergoes 
actin reorganization (Leitinger & Hogg 2000).  
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Reciprocally, the ligation of VLA-4 with VCAM-1 stimulates the LFA-1 to bind 
ICAM-1. LFA-1 clustering on the cell membrane induced and enhanced adhesion of 
LFA-1 to ICAM-1 ligand. In increased adhesion due to avidity change of LFA-1, there 
is no change in the open activation epitope of LFA-1 as measured with the mab24 
antibody (Chan et al. 2000). Importantly, it has been shown that phosphorylation of 
α4 on Ser-988 is needed for the trans-dominant regulation of the LFA-1. If the α4-
chain becomes constitutively active by mutating the aa Ser988 to Asp, the 
interaction of paxillin with the integrin is inhibited and it is unable to convey signals 
to LFA-1 (Han et al. 2003). 
Other β2 integrins have also been shown to exhibit crosstalk. In neutrophils, 
activation of β1 integrins via an activating antibody increased the Mac-1-dependent 
adhesion to fibronectin (Poloni et al. 2001). Some pathogens change the adhesion 
signaling in host cells via crosstalk mechanisms. For example, in whooping cough 
(Bordetella pertussis infection), activation of the β1 signaling pathway increases the 
bacterial adherence to monocytes or macrophages through Mac-1 integrin 
(Ishibashi et al. 1994). Moreover, CD11c is also reported to be involved in crosstalk 
in monocytes. After a high-fat meal, the expression of CR4 is increased together with 
VLA-4 which increases the adhesion of monocytes to aortic endothelium VCAM-1. 
This research suggested that in monocytes expression of CR4 not only facilitates the 
VLA-4 binding but also supports the VLA-4/VCAM-1 interaction (Gower et al. 2011).  
7.2 Crosstalk between other integrins  
Glazmann’s thrombasthenia is a disease where platelet aggregation is defective, and 
patients suffer from severe bleeding. The mechanism behind this disease is integrin 
crosstalk. It was found that mutation of Ser-752 to Pro on the β3 integrin inhibited 
the inside-out activation of αIIbβ3 in platelets, which consequently inhibited the 
α2β1-mediated collagen binding (Gonzalez et al. 2010). Another crosstalk 
mechanism is also seen in this disease like that the binding of fibrinogen to β1 
inhibits the collagen binding to β1 (Van de Walle et al. 2007, Riederer et al. 2002). 
Additional crosstalks have been reported between αvβ3 and α5β1integrins. Ligation 
of αvβ3 also speeds up the VLA-4-dependent migration on VCAM-1 as well as 
extravasation of the cells (Imhof et al. 1997). It has as well been shown that 
activation of the αvβ3 integrin inhibits ICAM binding of LFA-1 in monocytes 
(Weerasinghe et al. 1998). In phagocytosis, crosstalk of integrins has been reported. 
Blocking phagocytosis by αVβ3 integrin also inhibits the α5β1-mediated 
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phagocytosis. One study suggests that αVβ3 ligation inhibits α5β1-dependent 
phagocytosis without an effect on α5β1-mediated adhesion to fibronectin (Blystone 
et al. 1994). Later on, it was found that monocyte α5β1 is activated by 
Ca2+/calmodulin-dependent protein kinase II (CAMKII), which mediates 
phagocytosis and migration, and α5β1 can be inhibited by the interaction of 
integrin-asociated protein (IAP) with the β3 cytoplasmic tail (Blystone et al. 1995, 
Blystone et al. 1999). There is a report of crosstalk of αIIbβ3 and α5β1 integrins in 
platelets. Usually, cells bind to Fn via α5β1 integrin; however, upon the activation of 
αIIbβ3, binding and spreading of FN is reduced (Díaz-González et al. 1996). αVβ5-
mediated phagocytosis is vital for maintaining the physiological condition in the eye, 
and in glaucoma, it was found that activation of αVβ3 inhibited the αVβ5-mediated 
phagocytosis. Upon steroid treatment, αVβ3 was activated and inhibited αVβ5-
mediated phagocytosis, leading to glaucoma (Gagen et al. 2013). 
8. Clinical significance of leukocyte integrins 
The leukocyte adhesion cascade firmly controls leukocyte trafficking to the site of 
infection. The inflammatory response of endothelial and many other cells produces 
cytokines and chemokines, which promote leukocyte recruitment by inside-out 
activation of integrins and upregulation of the adhesion molecules on the surface of 
endothelial cells which function as counter-receptors of integrins (Gahmberg et al. 
2009). Too much or insufficient leukocyte recruitment to the inflamed site by 
integrins is a hallmark of several inflammatory diseases like multiple sclerosis (MS), 
psoriasis, inflammatory bone loss, inflammatory bowel disease and many more 
(Yonekawa & Harlan 2005).  
MS is an autoimmune disease that is characterized by demyelination in the 
central nervous system (CNS). In this disease, leukocytes are capable of penetrating 
the blood brain barrier, start attacking the neuron-protecting myelin sheath, and 
leave a lesion in the CNS (Lassmann et al. 2012). The involvement of VLA-4 in 
leukocyte recruitment to the inflamed CNS sites has been extensively studied 
(Sheremata et al. 2005). Natalizumab, a monoclonal antibody to α4 integrin has 
been approved for the treatment of MS (Weinstock-Guttman 2013). Initially it was 
shown in a rat model of MS that continuous blocking of VLA-4 reduces the disease 
lesions in the CNS (Yednock et al. 1992, Baron et al. 1993). Furthermore, several 
studies also elucidated the significance of β2 in this disease model. Gordon and 
others have used blocking antibodies against CD11a and CD11b and have shown 
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that targeting the β2 integrins also blocks or delays the onset of the autoimmune 
encephalomyelitis (Gordon et al. 1995). Blocking the adhesion of Mac-1 to the 
platelet GPIba (platelet specific receptor glycoprotein Iba) also blocks the 
leukocyte-platelet interaction, which is significant for the amelioration of the 
disease severity (Langer et al. 2012). 
An inflammatory disease of the skin is psoriasis. Usage of efalizumab, a 
monoclonal antibody against the αL chain in the treatment of psoriasis showed 
significant reduction of TNF, nitric oxide synthase production and the number of 
DCs in the lesion area (Lowes et al. 2005). It has as well been shown in vivo that 
blocking of Mac-1 together with LFA-1 improves the skin manifestations (Schön et 
al. 2000). 
Blocking of VLA-1 integrin, a collagen receptor, reduces the infiltration of T 
cells into dermis, in a in vitro transplantation psoriasis model. The presence of VLA-
1 in the epidermis activated effector T cells that increased the expression of 
interferon-γ (Conrad et al. 2007).  
One more inflammatory disease is rheumatoid arthritis (RA), where synovial 
inflammation occurs by infiltrating neutrophils, T cells, B cells, DCs, and 
macrophages (Choy 2012). The role of leukocyte integrins has been reported in RA 
in many animal models. For example, concomitant inhibition of LFA-1 and Mac-1 
completely blocks the neutrophil recruitment to the synovial inflammation 
(Issekutz & Issekutz 1993). Later on, the same group showed that blockage of LFA-
1 and VLA-4 are required for the total inhibition of monocytes (Issekutz & Issekutz 
1995). 
Additionally, VLA-2 was shown to stimulate arthritis in an antigen-induced 
arthritis (AIA) model. VLA-2-deficient mice show less cartilage loss and joint 
pathology compared with the wild-type (Peters et al. 2006).  
The central role of β7-integrins has been described in the formation of gut-
associated lymphoid tissue (Koboziev et al. 2010). The humanized monoclonal 
antibody etrolizumab specifically binds to the β7 integrin in both α4β7 and αEβ7 
heterodimers. This antibody provoked both α4β7-MAdCAM-1-mediated 
lymphocyte recruitment and αEβ7–E-cadherin interaction (Lin & Mahadevan 2014), 
and at the same time promoted adhesion of αEβ7 T cells to epithelial cells (Hadley 
& Higgins 2014). Several studies suggested a significant role of β2-integrins in a 
rodent experimental model (Palmen et al. 1995, Ostanin et al. 2007).  
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V. Aims of the study 
The aims of this study were 
 
 To discover signaling molecules downstream of LFA-1/14-3-3  
 To investigate how the inside-out and outside-in activations of the LFA-1 
regulate VLA-4 binding to its ligand VCAM-1 
 To investigate how the treatment with LFA-1-specific antibodies via outside-
in signaling activates LFA-1’s intracellular signaling and affects the VLA-4 
mediated adhesion to VCAM-1 
 To study how the phosphorylation of the LFA-1 α-chain regulates the function 
of the β2-chain 
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VI. Methods and experimental procedures 
Materials and methods used in this study have been described in detail in the 
original publications.  
Experimental procedure Original publications 
Reagents I        II   III IV 
Cell Culture I        II   III IV 
Antibodies I        II   III IV 
Immunoprecipitation I        II   III IV 
Co-immunoprecipitation I        II   III IV 
SDS-PAGE I        II   III IV 
Immunoblot I        II   III IV 
Affinity chromatography I           
siRNA I             
Rac-1 activity assay I        II     
Immunofluorescence I        II   III IV 
Cell adhesion assays (static)  II   III IV 
Cell adhesion assays (shear flow)       II   III  
Cell migration assays (Transwell) I        II   III  
Cell migration assays (chemotactic 
directional)    IV 
Flow cytometry      II   III IV 
T cells isolation from buffy coat 
cells I        II   III  
Stable cell line production       II     
Pep-spot assay    IV 
Peptide transfection     II    IV 
DNA transfection    IV 
Adhesion complex isolation    IV 
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VII. Results and Discussion 
1. Tiam1 is found as a novel interacting protein in the 
complex of 14-3-3 and β2–chain in the intracellular 
signaling from LFA-1  
1.1 Tiam1 links the phosphorylated LFA-1 to Rac activation 
The cytoplasmic proteins 14-3-3, filamin, talin, kindlin, and α-actinin are involved 
in the intracellular signaling of LFA-1. Phosphorylations and dephosphorylation of 
the β2-chain regulate the interaction of these proteins with LFA-1, but the complete 
mechanisms of the regulation are not entirely understood (Gahmberg et al. 2009). 
Phosphorylation of the β2-chain on Thr-758 causes filamin release from the β2-tail 
and simultaneously promotes 14-3-3 binding to the phosphorylated β2 integrin, 
which activates Rac-1 (Nurmi et al. 2007). However, how phosphorylated β2 
integrins via 14-3-3 binding activate Rac and finally actin cytoskeletal 
reorganization was not known. We were interested in Tiam1 as the potential Rac-
GEF for a 14-3-3 binding partner. Tiam1 is a Rac-specific GEF and interacts with 14-
3-3 in HeLa cells and transfected Cos-7 cells (Pozuelo Rubio et al. 2004; Woodcock 
et al. 2009). 14-3-3 proteins do not bind directly to G proteins but are instead 
involved in protein regulation interacting with other proteins (Jin & Li 2002). To 
investigate if Tiam1 delivers signals from LFA-1 and 14-3-3 to Rac1, co-
immunoprecipitation experiments were done with JE6.1 Jurkat cells. These showed 
that Tiam1 was pulled down with 14-3-3 and vice versa and the 14-3-3–Tiam1 
complex was also found in β2 precipitation experiment. Thus, Tiam1 formed a 
complex with β2 and 14-3-3 (I, fig. 1A & B).  
The β2–14-3-3–Tiam1 complex was seen in both non-stimulated and anti-
CD3 stimulated T cells but more protein was seen in the complex in the stimulated 
cells as compared to non-stimulated cells. We knew from before that TCR activation 
by anti-CD3 leads to the phosphorylation of Thr-758 in the β2-chain of LFA-1 (Pazos 
et al. 2017) and more 14-3-3 binds to pThr-758 (Fagerholm et al. 2002). Next, our 
quest to answer whether the activation of T cells affects the Tiam1 interaction with 
14-3-3. Therefore, unstimulated and stimulated T cells with anti-CD3 were put over 
14-3-3-conjugated Sepharose columns, and found that more Tiam1 bound with 14-
3-3 from activated cells (I, fig. 1D and 2A). Next, we determined whether Tiam1 
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directly binds to the β2-chain or interact to the β2 via 14-3-3. For this, we blocked 
14-3-3 interaction with the β2 integrins with the peptide R18 
(PHCVPRDLSWLDLEANMCLP). We conjugated two short peptides corresponding to 
the β2’s cytoplasmic tail containing phosphorylated (CLFKSApTTTVMN) and non-
phosphorylated (CLFKSATTTVMN) Thr-758 with Sepharose beads. Afterward, we 
blocked all the 14-3-3 binding sites using the peptide R18 or– as a control – P621 
peptide (VDVDSDGSTDLVIGA) with the pβ2/β2 bound Sepharose column and 
incubated with unstimulated JE6.1 Jurkat cell lysates. Significantly more 14-3-3 and 
Tiam1 interacted with pβ2 compared to the β2 column, and when 14-3-3 was 
blocked, no or rare interaction of 14-3-3 and Tiam1 was visible irrespective of the 
phosphorylation of β2 (I, fig2B). Hence, 14-3-3 is required for LFA-1/Tiam1complex 
formation. 
Very little is known about the signaling pathway by which Tiam1 is controlled 
in T cells. Tiam1 has been reported as a specific activator for the Rho-like GTPase 
Rac (Mertens et al. 2003). It was shown before that chemokine-activated Rap1 
triggered Par polarity complex with PKCζ and consequently activates Tiam1 and 
then Rac1, which is essential for T cell polarization (Gérard et al. 2007). We also 
showed that Tiam1 activates Rac1 and actin cytoskeletal reorganization. For that, 
we knocked down Tiam1 by siRNA in JE6.1 Jurkat cells and looked for active Rac1 
which was determined by the PAK-PBD (p21 activated kinase–p21 binding domain) 
agarose. We found that introduction of Tiam1 targeting siRNA reduced active Rac1 
whereas control siRNA had no effect. Inhibition of Tiam1 also decreased the total 
active Rac-1 both in JE6.1 Jurkat and T cells (I, fig 3A & B). Thus, we found that in 
Jurkat cells the Tiam1 complex with activated β2 is a prerequisite for Rac-1 
activation after TCR activation. Tiam1 is also a crucial player in α3β1 integrin-
facilitated activation of Rac, which is vital for the production and the secretion of the 
laminin-5 protein (to the new nomenclature it is called as α3β3γ2, laminin-332 
(Aumailley et al. 2005)). Laminin-5 is required for spreading and migration of 
keratinocytes (Hamelers et al. 2005). Recently, it was shown that Tiam1 activates 
Rac through an association with the transmembrane cysteine-rich protein 
Semaphorin4D, which promotes cell proliferation, invasion and metastasis in oral 
squamous cell carcinoma (OSCC) cells (Zhou et al. 2017). 
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1.2 Tiam1 is required for LFA-1-mediated cell adhesion and 
migration  
Tiam1 is reported to increase or decrease cellular adhesions and migrations 
depending on the cell lines (Minard et al. 2004). Malliri et al. 2004 found that Tiam1 
was involved in the formation and the maintenance of cadherin-dependent 
adhesions in fibroblasts. We were interested in observing the effect of Tiam1 in T 
cell adhesion since it has been shown before that Rac1 regulates integrin-mediated 
adhesion (D’Souza-Schorey et al. 1998). The Tiam1 inhibitor (N6-[2-[[4-
(diethylamino)-1-methylbutyl] amino]-6-methyl-4-pyrimidinyl]-2-methyl-4,6-
quinolinediamine trihydrochloride) inhibited 60% of the anti-CD3-activated T cell 
adhesion to its ligand ICAM-1 (I, fig. 3C). So it seems that Tiam1 is involved in Rac 
dependent cell adhesion in T lymphocytes. Chemokine signaling regulates several 
signaling events in lymphocytes, including the Rac activation (Kinashi 2005, Zhou et 
al. 2017). T cells migrate towards the chemotactic attractants (Springer 1994). We 
showed here that chemokine activation phosphorylated the β2 integrin on Thr-758 
and increased cell migration. This migration was LFA-1-dependent as cells migrated 
on ICAM-1 and this migration was reduced when LFA-1–ICAM-1 binding was 
blocked by the LFA-1-specific blocking antibody 7E4. We then studied whether 
Tiam1 was required for migration and we found that treatment of cells with the 
Tiam1 inhibitor reduced cell migration as well as the LFA-1 blocking 7E4 antibody. 
These results showed that Tiam1 is required for LFA-1-dependent cell migration 
towards the chemokine SDF-1α (I, fig 4 A, B, and C). Next, we aimed to elucidate if 
the migration was dependent on the signaling pathway from pβ2–14-3-3–Tiam1. 
Therefore, cells were transfected either with the β2 or pβ2 peptide to activate 
downstream signaling, and the migration assay was performed. Activation of the 
downstream signaling of LFA-1 by phosphorylation of Thr-758 on the β2-chain 
doubled the number of migrating cells and migration was significantly inhibited by 
incubating with the Tiam1 inhibitor and with R18 (14-3-3 blocking) peptide (I, fig 
5A, B, & C). Thus, 14-3-3 and Tiam1 were required downstream of LFA-1 signaling 
for migration. Active Tiam1/Rac drives invasion of T-lymphoma cells on fibroblasts 
via activation of lysophosphatidic acid (LPA) and sphingosine one phosphate (S1P) 
receptor-mediated Rho A and PLC signaling (Stam et al. 1998). Activation of Tiam1 
is a prerequisite for actin cytoskeleton reorganization during neuronal cell 
migration and neurite extensions (Ehler et al. 1997). These results correspond to 
our observations.  
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Tiam1 localize differently in cells depending on the morphology and 
differential phase of the cells. In non-motile fibroblast cells Tiam1 localizes to the 
adherens junctions, while Tiam1 is found in the lamellae of migrating cells (Sander 
et al. 1998). In this study, Tiam1 formed a capped like structure with LFA-1 in 
activated JE6.1 Jurkat cells. The inhibitor against Tiam1 inhibited the formation of 
capped like structure of Tiam1 in Jurkat cells (I, fig. 6A, B). LFA-1 can adopt in three 
conformational stages: bent, extended and open-extended as also mentioned earlier. 
In our hands (immune fluorescence experiments), we observed that activation of 
Jurkat cells by anti-CD3 and SDF-1α- increased the numbers of extended 
conformational state of LFA-1 as detected with KIM127 antibody. However, 
conversely, the open-extended conformation of LFA-1, recognized by mab24 was 
found only in anti CD3-activated cells (I, fig. 6 A–E). It may be due to the lack of the 
spreading and sheer force that this experimental setup was unable to open the 
mab24 epitope after SDF-1α- activation or the activation is too rapid to observe. It 
has recently been shown in neutrophils that β2 integrins can interact with ICAM-1 
also in bent conformation which subsequently inhibits leukocyte adhesion (Fan et 
al. 2016). Tiam1 is reported as a vital player for Rac/Rho activation in many 
signaling pathways. Tiam1 may also be involved in cell division (Chen et al. 2012). 
PAK, a downstream effector of Rac1, promotes gene transcription and regulates cell 
division by MAP kinase pathway. For that reason, Rac activation via Tiam1 indorses 
cells division and cell migration. Importantly, Tiam1 is found to be overexpressed 
in many malignancies including T cell lymphomas. Tiam1 knockout mice show 
impaired carcinogen-induced HRAS (the gene for H-Ras enzyme) activation which 
prevented skin carcinoma formation (Vigil et al. 2010).  
2. Intracellular activation of LFA-1 transmits signals to 
the leukocyte integrin VLA-4 
2.1 LFA-1 inhibits adhesion of VLA-4 to its ligand VCAM-1 
T cells express different kinds of integrins, of which LFA-1 and VLA-4 are mainly 
important for the adhesion to endothelial cells. These integrins play different 
functions in the cascade of transmigration. VLA-4 mediates cell tethering and rolling 
along with firm adhesion (Alon et al. 2005), while LFA-1 takes part in the formation 
of strong adhesions and regulates migration on the endothelial (Hogg et al. 2011b). 
Little known how integrins work together. They can be regulated seperately but also 
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regulate the function of each other. Crosstalk between LFA-1 and VLA-4 in 
leukocytes was first observed in 1993 (van Kooyk et al. 1993). Crosstalk among 
different integrin subclasses has also been reported in many other cells. It has been 
shown that when one integrin is activated, it affects the ligand binding of other 
integrins (Chan et al., 2000), but the mechanisms behind this are not well 
understood.  
Jβ2.7 is an αL-chain lacking (Jβ2.7/LFA-1 negative) Jurkat cell, derived from 
the parental Jurkat T cell line (Weber et al. 1997), lacking LFA-1 expression on the 
cell surface. To study crosstalk between LFA-1 and VLA-4 we made Jβ2.7 Jurkat cells 
stably expressing LFA-1 (Jβ2.7/LFA-1 positive) by transduction (Uotila et al. 2014). 
We verified the expression of LFA-1 and VLA-4 on the surface of Jβ2.7/LFA-1 cells 
by flow cytometry. During the extravasation cascade of leukocytes, VLA-4 is 
reported to participate in cell tethering, rolling and arrest (Shamri et al. 2005), 
whereas LFA-1 is involved in tight adhesions on the endothelium (Hogg et al. 2011a). 
Jurkat cells are reported to adhere well to VCAM-1 through VLA-4 (Manevich et al. 
2007). We showed that Jurkat cells which don’t express LFA-1 on the surface, 
interacted with VCAM-1 only via VLA-4, as we could block VLA-4 binding using 
blocking antibody towards α4 or β1 which blocked VCAM-1 interaction. The binding 
of VLA-4 to VCAM-1 was also inhibited when LFA-1 was expressed, and activated by 
SDF-1α. Significantly more inhibition was observed both from the static and flow 
adhesions on purified VCAM-1 as well as on the activated endothelium. Jβ2.7/LFA-
1-negative cells spread and made long extensions as well as bound strongly to 
VCAM-1 as compared to the Jβ2.7/LFA-1expressing cells (II, fig. 1A–E).  
The firm adhesion of VLA-4 and VCAM-1 was also seen in the Transwell 
migration assays. Jβ2.7 cells lacking the LFA-1 on the surface were unable to 
transmigrate through VCAM-1 coated filters towards chemokines. These stable 
adhesions were released and cells were able to migrate when cells were treated 
either with α4- or β1-blocking antibodies or upon the expression of LFA-1. 
Furthermore, the long extensions from the Jβ2.7 on VCAM-1 also started retracting 
with time and disappeared almost completely after 120 minutes (II, Fig. 2 A–C). 
2.2 LFA-1 signaling through pThr-758 β2, 14-3-3 and Tiam1 
causes transdominant inhibition of VLA-4 
Naive T cells adhere to ligands via LFA-1 and VLA-4, but blasts T cells adhere mainly 
via LFA-1, even though the expression of LFA-1 and VLA-4 stays the same (van 
Kooyk et al. 1993). In the activated T cells, VLA-4 is involved in slowing down the 
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rolling cells while LFA-1 captures the cells and promotes adhesion on endothelium 
(Porter & Hogg 1997). We saw that the occupancy of LFA-1 induces crosstalk to 
VLA-4. Transfection of the pThr-758 β2 peptide was enough to initiate the β2 
signaling pathway (Grönholm et al. 2011). When we introduced the pβ2 peptide but 
not the β2 peptide to the Jβ2.7/LFA-1 negative Jurkat cells, it inhibited the adhesion 
of VLA-4 to its ligand VCAM-1. We were then interested in knowing whether the 
transdominant inhibition of VLA-4 happened via the pThr-758/β2–14-3-3–Tiam1 
signaling pathway. Hence, we treated the cells with the 14-3-3- blocking peptide 
R18 or the Tiam1 inhibitor before performing flow adhesion experiments on VCAM-
1, and indeed, pThr-758 β2-mediated transdominant inhibition was overruled with 
these inhibitors. These results suggest that 14-3-3 and Tiam1 are necessary for the 
crosstalk of VLA-4 inhibition to the ligand VCAM-1(II, fig.5A–C). 
2.3 LFA-1 activation leads to changes in the phosphorylation 
status of VLA-4 and consequently affects protein-protein 
interactions 
As we described that the activation of LFA-1 caused the phosphorylation of Thr-758 
in the β2-chain and therefore inhibited the VLA-4 ligand binding, we were 
interested in studying the effect of the phosphorylation state of the β1 integrins and 
adaptor protein binding. The importance of phosphorylation of Thr-788/789 of the 
β1 integrins (Thr-788/789 sites of β1 integrin corresponds to the triple Thr-758–
760 of the β2 integrin) have been described before. The phosphorylation of Thr-
788/789 of β1 is necessary for fibronectin binding and for the expression of the 
activation epitope (Wennerberg et al. 1998). Mutation of the Thr-788 to Asp that 
mimics the phosphorylation of the β1 integrin is shown to induce active β1 and 
increase cell adhesion via inside-out activation (Nilsson et al. 2006). Suzuki and 
Takahashi reported that dephosphorylation of Thr-788/789 of β1 reduces β1-
mediated adhesion to laminin in human mammary epithelial cells and that 
phosphorylation of β1 reduces the β1 association with the actin cytoskeleton 
(Suzuki & Takahashi 2003). It has also been shown in cancer cells that extracellular 
pressure induces phosphorylation of β1 in Thr-788/789 which increases integrin 
affinity (Craig et al. 2009). Phosphorylation of α4 regulates the dynamic adhesion 
events in Jurkat cells through the regulation of paxillin binding (Han et al. 2001). 
Ser-988 phosphorylation on α4 was found to be equally strong despite the active 
expression of LFA-1 on the cell surface. However, we observed that after SDF-1α 
activation, there was a drastic reduction of the phosphorylation of Thr-788/789 of 
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β1 in Jβ2.7/LFA-1 positive cells, but not in Jβ2.7/LFA-1 negative cells (II, fig. 6A). 
Next, we investigated how the adaptor proteins were involved in the regulation of 
integrin activity. 14-3-3ζ has been reported to bind more to the phosphorylated β2 
integrin, which facilitated Tiam1 interaction with the β2–14-3-3 complex and 
further activated Rac-1 (Nurmi et al. 2007; Grönholm et al. 2011). The cytoplasmic 
tail of β1 also interacts with filamin, 14-3-3 and talin (Legate & Fassler 2009). 
Filamin is reportedly a negative regulator of integrin activation (Takala et al. 2008). 
Filamin was found to interact with VLA-4, only when LFA-1 was present and 
activated, whereas 14-3-3ζ binding to VLA-4 was decreased in cells expressing 
active LFA-1. In contrast, when LFA-1 was activated, it bound to14-3-3 and not to 
filamin (II, fig. 6A and B). LFA-1 interacts with 14-3-3 only through the β2-chain 
whereas VLA-4 binds with 14-3-3 via both the α and β chains. Phosphorylation of 
α4 on Ser-978 integrin engages 14-3-3ζ binding and further forms a complex with 
paxillin, which activates the Rho GTPase Cdc42 at the leading edge of migratory 
leukocytes. In contrast, the interaction between α4 and paxillin is enough to regulate 
the function of another Rho GTPase, Rac1 (Deakin et al. 2009). Mutation of the Ser-
978 to Ala of the α4 integrin blocked migration as well as reduced lamellipodia 
stability, but the affinity of the ligand binding remained constant (Goldfinger et al. 
2003). The affinity of 14-3-3ζ to the phosphorylate β2 was higher as compared to 
the phosphorylated α4 (Bonet et al. 2013). The cytoplasmic tail of the β1 interacted 
with 14-3-3ζ regardless of the phosphorylation of the β1, but the 14-3-3 interactions 
with β1 was much weaker than with the phosphorylated α4 and β2 polypeptides 
(Bonet et al. 2013). Thus activation of LFA-1 leads to the phosphorylation of β2 
integrin that sequestered the 14-3-3 proteins and facilitated filamin binding to the 
β1 chain and inhibited VLA-4–VCAM-1 interaction.  
We also studied the distribution of α4, talin, and phalloidin in Jβ2.7/LFA-1 
negative and Jβ2.7/LFA-1 positive Jurkat cells. We found that more α4 and talin 
were co-localized with phalloidin in the LFA-1 negative cells than in LFA-1 positive 
cells. Confocal microscopy data suggested that filamin stayed firmly on the adhesion 
sites whereas talin and 14-3-3 localized to the membrane of the non-migratory, 
LFA-1 negative cells (II, fig. 6D and E). Because of the absence of the LFA-1, adhesion 
with the ligand took place via VLA-4 and thus more α4, talin and 14-3-3 were found 
in the adhesion sites. 
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3. LFA-1-specific antibodies induce crosstalk from LFA-
1 to VLA-4 
3.1 LFA-1-specific antibodies differently regulate VLA-4–
VCAM-1 binding 
Integrins communicate bi-directionally across the plasma membrane. As also 
mentioned earlier outside-in signals happen by binding of ligands or antibodies to 
integrins, whereas inside-out signals are due to the ligand binding to non-integrin 
receptors, such as chemokine receptors or the T-cell receptor. After studying how 
inside-out activation of LFA-1 affects VLA-4 adhesion we wanted to study the 
crosstalk to VLA-4 after the activation of LFA-1 via outside-in signaling. Therefore, 
in this investigation, we used antibodies that target LFA-1. The use of neutral, 
activating or blocking antibodies for targeting the integrins is one of the consistent 
tools for the study of integrin regulation. Activating antibodies stimulate ligand 
engagements or conformation resulting in intracellular signaling, inhibiting 
antibodies are those that impede ligand engagement and neutral antibodies usually 
do not have any effect on integrin regulation (Byron et al. 2009). These three 
categories of antibodies can bind to the same or different domains (Schiffer et al. 
1995) of LFA-1.  
The binding epitopes and functionality (activating, inhibiting or neutral) of 
the antibodies towards LFA-1 used in our study were mapped before. However, 
we verified them by static adhesion assays on ICAM-1. Static adhesion showed that 
treatment of activating antibodies increased ICAM-1 binding, inhibiting 
antibodies blocked ligand binding, whereas neutral antibodies did not have any 
effect on integrin–igand interaction (III, fig.1A, and B). Transdominant inhibition 
of VLA-4 with its ligand VCAM-1 was observed in the flow adhesion assay of Jβ2.7 
Jurkat cells and T blast cells with the LFA-1-specific activating antibodies CBR1/2, 
MEM48 and MEM148. Strong transdominant inhibition was observed with the 
inhibiting antibody 7E4 and, a slight inhibition with TS1/18, but not with MHM24, 
MHM23, and TS1/22. Neutral antibodies did not have any effect on the 
transdominant inhibition of VLA-4. The transdominant inhibition of VLA-4 by 7E4 
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Figure 15: Binding sites and effects of antibodies against LFA-1. B. A schematic picture of 
LFA-1 αL- and β2-chains and the binding sites of the antibodies used. Yellow stars indicate 
the phosphorylation sites Ser-1140 at the α-chain and Thr-758 at the β-chain. The binding 
sites for talin and 14-3-3 are shown in blue and red, respectively. 
In figure 15 is shown the regulation of integrin–ligand interaction by 
antibodies based on the antibody-binding sites on the extracellular domain of the 
integrin. Activating antibodies towards LFA-1 initiate inhibitory signals to VLA-4, 
but inhibitory antibodies towards LFA-1 show variable effects. Antibodies that 
bind more towards the C-terminal are activating or neutral, and antibodies that 
bind to the αI domain or the βI like domain are usually inhibitory (Huang et al. 
2000).  
3.1.1 Activating antibodies towards LFA-1 
CBR1/2 and MEM48 are activating antibodies, which bind to the I-EGF-3 repeat 
region in the β2-chain (Petruzzelli et al. 1995; Bazil et al. 1990) of LFA-1. When 
CBR1/2 and MEM48 bind to the I-EGF-3 domain of the β2-chain, β2 moves away 
from the αL-chain and becomes activated for ligand binding (Nishida et al. 2006). 
This activation consequently phosphorylates Thr-758 of the β2 integrin and alters 
protein-protein interactions. Another β2-activating antibody is MEM148. It binds to 
the β2-hybrid domain facing towards the αL’s β-propeller domain (Chen et al. 2010). 





CBR1/2 β2 I-EGF-3 ACTIVATING  
MEM48  β2 I-EGF-3  ACTIVATING 
MEM148 β2 HYBRID  ACTIVATING 
7E4 β2 HYBRID INHIBITING  
TS1/18 β2 β I-LIKE INHIBITING  
MHM23 β2 β I-LIKE INHIBITING 
CBR1/7 β2 I-EGF-1  NO EFFECT 
MEM83 αL α I-DOMAIN ACTIVATING 
TS1/22 αL α I-DOMAIN INHIBITING 
MHM24 αL α I-DOMAIN INHIBITING 
TS2/4 αL  β PROPELLER  NO EFFECT 
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Bound MEM148 stabilizes the active conformation of LFA-1 and increases ligand 
binding affinities. MEM83 is reported to be an αL-specific activating antibody, and it 
binds to the I-domain of the αL chain. MEM83-binding residues are situated in the 
front of the αL-I that is opposite and far from the ligand binding site (Lu et al. 2004). 
MEM83 also causes inhibition of VLA-4 binding to its ligand, VCAM-1 but less 
efficiently than CBR1/2 and MEM48. MEM83 increases the ligand-binding affinity 
by changing the orientation of the I domain, which in turn makes it more accessible 
for ICAM-1. 
3.1.2 Inhibitory antibodies towards LFA-1 
7E4, TS1/18, and MHM23 are inhibitory antibodies specific for the β2-chain of LFA-
1–ICAM-1 binding. MHM23 binds to the loop between the β1and β3 strands in the 
β-I like domain (Hildreth et al. 1983). We did not see any inhibition of VLA-4 with 
this antibody. On the other hand, TS1/18, another blocking antibody also binds the 
βI like domain (Sanchez-Madrid et al. 1982), and we observed mild inhibition of 
VLA-4 upon TS1/18 treatment. The 7E4 inhibitory antibody (NORTAMO et al. 1988) 
of β2 binds to the hybrid domain and inhibits ligand binding, and simultaneously 
caused the phosphorylation of the Thr-758 of the β2-chain. The epitopes for both 
7E4 and TS1/18 alter their orientation when integrins shifts to the open 
conformation. Binding of these both antibodies stabilizes the closed conformation 
and block ligand binding (Chen et al. 2010), but simultaneously may cause a 
conformational change of the cytoplasmic domain of the LFA-1 that results in 
intracellular signaling, similar to the activating antibodies. TS1/22 and MHM24, two 
of the αL- specific blocking antibodies bind to the α-I domain (Hildreth et al. 1983; 
Lu et al. 2004b) and inhibit ICAM-1 ligand binding. Only MHM24 induced minimal 
crosstalk to VLA-4, like the αL-activating antibody MEM83. The reason behind this 
slight inhibition of VLA-4 by MHM24 might be the binding region of MHM24, which 
is very close to the binding site of MEM83. Both of these antibodies bind the αL-I 
domain. The epitope for MEM83 is the β3–α2 loop and the α4 helix residues 153–
183 and 217–248, while MHM24 binds to the α4 loop residues 197–201. On the 
other hand, TS1/22 did not show a crosstalk effect. Its binding region is further from 
the MEM83 in the C-terminal end of the β5–α6 loop and the short α6 helix residues 
266–270 (Lu et. 2004). 
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3.1.3 Neutral antibodies towards LFA-1 
Two neutral antibodies CBR1/7 and TS2/4 were used as control antibodies in this 
study. CBR1/7 binds to the first EGF-I domain of the β2 chain (Lu et al. 2001) and 
TS2/4 to the β-propeller on the αL-chain (C. Huang 1997).  
3.2 The crosstalk from LFA-1 to VLA-4 involves the 
phosphorylation of PLC 
We have described that the transdominant inhibition of VLA-4 by LFA-1 facilitated 
intracellular signaling and requires phosphorylation of β2, which therefore alters 
the protein-protein interactions (Uotila et al. 2014). We showed that treatment 
with activating (CBR1/2, MEM48) and inhibiting (7E4) antibodies of both 
Jβ2.7/LFA-1-expressing Jurkat and T–blasts resulted in the phosphorylation of the 
β2- chain on Thr-758 (III, fig. 4A, and B). Moreover, we observed that the 
phosphorylation of β2 was the result of the phosphorylation of PLCγ1 on Tyr-783 
and PLCβ3 on Ser-1105 after the antibody treatments (III, fig. 4A, and B). SDF-1α 
activation causes phosphorylation of PLC which in turn catalyzes the cleavage of 
PIP2 into IP3 and DAG. DAG activates PKC which then phosphorylates Thr-758 on 
the β2-chain (Gahmberg et al. 2002). Activation of LFA-1 via ICAM-1/Rg (soluble 
Ig C gamma1 fusion chimeras called receptor globulins) fusion protein causes the 
phosphorylation of Tyr on PLCγ. Monoclonal antibodies to both the αL and β2 
chains induced different levels of Ca2+ mobilization in the cells, which suggests 
that activation of LFA-1 may depend on the epitope for antibody binding (Kanner 
et al. 1993). We also think that antibodies to LFA-1 may change the conformation 
of the integrin which can signal into the cells, cause the phosphorylation of PLC 
and thus activate PKC. By contrast to our results, Caiping Yue showed that the 
activation of Gq-coupled receptor leads the phosphorylation of Ser-1105 on PLCβ3 
which inhibits PKC activity in Hela, COSM6, and RBL-2H3 cells, although by PMA 
activation PKC inhibition is not apparent (Yue et al. 2000). Thus it seems that upon 
ligand binding, specific signaling pathways were induced that lead to increase or 
decrease of cell adhesion or migration, although the final result depends on cell 
types and its characteristics.  
We showed that the signal of transdominant inhibition of α4β1 by LFA-1 
activating antibodies and 7E4 required Tiam1 involvement (III, fig. 5A, B, and C) and 
dephosphorylation of the β1-chain, which then altered protein-protein interactions 
(III, fig. 6A, B, E, and F). Another phenomenon is that VLA-4 mediates rolling of cells 
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and simultaneously conveys activation signals, which enhances the LFA-1 
interaction with ICAM-1 and this interaction is required for firm adhesion (Chan et 
al. 2000). An intact cytoskeleton is required for the crosstalk of integrins (Leitinger 
& Hogg 2000). Treatment of cells with cytochalasin D decreased the stimulated 
interaction of LFA-1 and ICAM-1. However, the basal adhesion of LFA-1 to ICAM-1 
and activation of LFA-1 (detected by mab24 positivity) were not changed. These 
observations strongly suggest that the increase in LFA-1 ligand binding via 
activation of VLA-4 is dependent on the cytoskeleton and LFA-1 avidity. We also saw 
that adding of cytochalasin D to MEM48 and 7E4 treated Jβ2.7/LFA-1-expressing 
cells reversed the VLA-4 binding to VCAM-1 in the flow adhesion experiments (III, 
fig., 5D). Treatment with cytochalasin D was also able to restore the 
phosphorylation of the β1 integrin in the activated Jβ2.7/LFA-1 expressing Jurkat 
and T cells (III, fig. 6C). Therefore we conclude that antibodies against LFA-1 can 1) 
activate LFA-1 and inhibit α4β1, 2) inhibit both LFA-1 and α4β1, 3) inhibit LFA-1 
but not α4β1, or 4) not affect LFA-1 or α4β1.  
4. α-chain phosphorylation regulates β2-integrin 
functions 
The cytoplasmic tails of integrins are short and lack catalytic activity. Several 
proteins compete with each other for the interaction with the short β2-cytoplasmic 
domain. The cytoplasmic parts of the αL, αM, αX and αD chains of β2 integrins differ 
in length and sequence. Phosphorylation of the cytoplasmic tails of integrins is an 
important way of regulating adaptor protein interactions with integrins (Gahmberg 
et al. 2009). The phosphorylation of the α- and the β-chains is reported to be 
constitutive or to take place upon activation, respectively (Fagerholm et al. 2004; 
Buyon et al. 1990).  
4.1 αL and αX phosphorylation is required for the 
transdominant inhibition of VLA-4 after chemokine 
activation 
The αL, αM, and αX polypeptides have been reported to be phosphorylated on Ser-
1140, Ser-1126 and Ser-1158, respectively (Fagerholm et al. 2005; Fagerholm et al. 
2006; Uotila et al. 2013). Phosphorylation of αL on Ser-1140 affects LFA-1–ICAM-1 
binding and the expression of the open conformation of LFA-1. Therefore, we made 
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a Jβ2.7 Jurkat cell line stably expressing the phosphorylation mutant of αL 
Ser1140Ala (Jβ2.7/LFA-1 αL mutant), and we wanted to know how the mutation in 
Ser-1140 to Ala on the αL-chain regulates the LFA-1 and VLA-4 adhesion to their 
ligands. We found that the Jβ2.7 Jurkat cells carrying the mutated αL-chain were 
unable to detach the uropod and instead left long extensions while migrating on 
VCAM-1, similar to Jβ2.7/LFA-1 negative cells (III, fig. 3A–C). Because of the 
mutation in the αL chain, cells adhered tightly to VCAM-1, which prevented 
migration. The same phenomena were also seen in K562-αXβ2-transfected cells. 
K562 cells were able to inhibit the VLA-4 mediated adhesion to VCAM-1 only when 
they express the wt αX (III, fig. 3D)  
A significant fraction of the αL-chains is phosphorylated in Jurkat cells. 
Approximately 40% of total αL chains of LFA-1s are found in the phosphorylated 
form (Fagerholm et al. 2005). Interestingly, αL phosphorylation is partially 
dependent on the activation of LFA-1s. Cells expressing the mutated αL-chain are 
not affected by phorbol ester activation, as it does with activating antibody 
MEM83 or Mg2+. Jβ2.7/LFA-1 αL mutant-expressing cells bind less efficiently to 
ICAM-1 (Fagerholm et al. 2005). We also found that when the cells were activated 
with SDF-1α, the phosphorylation of the αL-chain was essential for the 
transdominant inhibition of VLA-4. However, the transdominant inhibition of 
VLA-4 to its ligand VCAM-1 was independent of αL phosphorylation when LFA-1 
was activated by anti-CD3 or ligand ligation (II, fig. 4A and B). As the 
phosphorylation of the αL-chain also affects the conformation of the integrin, we 
studied the activation stages of the LFA-1 for transdominant inhibition of VLA-4 
using epitope-specific antibodies. We found that the KIM127-epitope (recognizing 
the extended conformation) was expressed irrespective of activation and 
mutation of the αL-chain. However, the mab24-epitope (recognizes open-
extended) was expressed only in wt αL-expressing Jurkat cells when cells were 
activated by SDF-1α or anti-CD3 or via ligand interaction (II, fig. 4 C, and D). The 
NKI-L16 monoclonal antibody towards LFA-1 reacts with the unique epitope, 
called L16, on the α-chain in activated JS-136 T cells and is also capable of inducing 
cell adhesion by LFA-1–ICAM-1 (van Kooyk et al. 1989). By FACS assays, we found 
that the activation epitope defined by L16 is only expressed in the αL-wt-
expressing T cells after SDF-1α activation but not in the αL-mutant-expressing T 
cells (IV, fig. 4 C). However, the L16 epitope expression was seen both in the αL-
wt and αL-mutant-expressing T cells after anti-CD3 activation. The L16 epitope 
seems to appear only after stimulation of naive T lymphocytes with similar 
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kinetics as the conversion of LFA-1 from the low to the high avidity state (Larson 
et al. 1990). Previously we reported that the SDF-1α was incapable of activating 
Jurkat Jβ2.7/LFA-1 αL mutant-expressing cells (Fagerholm et al. 2005). 
Importantly, the αM chain with a mutation of Ser-1126 to Ala in was not able to be 
activated by phorbol esters or extracellular Mg2+/EGTA treatment which 
consequently affects ICAM-1and ICAM-2 binding. However, this mutation in αM 
did not change the binding of the ligand iC3b or denatured BSA (bovine serum 
albumin) (Fagerholm et al. 2006). Mutation in the αM chain severely affected 
homing of lymphocytes and migration on endothelium in vivo (Fagerholm et al. 
2006). Transdominant regulation of β1 integrins by Mac-1 has also been reported 
in neutrophils (Poloni et al. 2001). In whooping cough, activation of β1 integrins 
enhances the adhesion of bacterium to monocytes/macrophage via Mac-1 
activation (Ishibashi et al. 1994).  
4.2 Phosphorylation of the αL-chain is important for β2 
phosphorylation and protein interactions with the β2-
chain 
There are many signaling, adaptor, and cytoskeletal linker proteins which can 
interact with the β-chain of LFA-1 (Legate & Fassler 2009). In contrast, very few 
proteins are known to bind specifically to the α-chain of LFA-1(Abram & Lowell 
2009). The regulation of the integrins via interactions of these proteins with the 
cytoplasmic parts of the integrins is still poorly understood. Phosphorylations of the 
α- and β-chains are important in the regulation of integrin’s function and protein-
protein interactions (Grönholm et al. 2011). As mentioned earlier, a significant 
fraction of the α-chains of leukocyte integrins are phosphorylated (Fagerholm et al. 
2005), while the β-chains become phosphorylated upon activation through SDF-1α, 
TCR or phorbol esters (Chatila et al. 1989, Valmu et al. 1999, Hilden et al. 2003, 
Fagerholm et al. 2005). We have now shown that the mutation of Ser to Ala at 1140 
on the αL-chain, inhibits the phosphorylation of Thr-758 of the β2-chain and the 
conformational activation of LFA-1, which results in changes in protein interactions 
with the cytoplasmic tail of the β2-chain. We used Jurkat Jβ2.7/ LFA-1 αL wt and αL-
expressing the Ser1140Ala mutation to elucidate the importance of the αL serine 
phosphorylation. There are three conserved regions, the two NPXY/F sequences 
and the Ser/Thr sequence between them in the β2-tail. GFFKR, a motif in the α-chain 
is also conserved. Initially, it was shown that mutations of Thr-758 to Ala in the β2-
tail leads to the retraction of cell adhesion to ICAM-1 (Hibbs et al. 1991). Using 
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okadaic acid, a robust phosphorylation of Thr-758 was observed after activation of 
the cells by a phorbol ester, through TCR ligation or, SDF-1α treatments (Valmu & 
Gahmberg 1995, Hilden et al. 2003, Abram & Lowell 2009, Uotila et al. 2014). GFFKR 
in the αL-chain is essential to keep the integrins in an inactive conformation, and 
when this motif is deleted, the integrins become active (Hughes et al. 1995). 
Importantly, the Thr-758 β2 phosphorylation was not seen in SDF-1α- or anti-CD3-
activated, αL mutant-expressing Jurkat cells as compared to the αL wild-type (IV, fig. 
1B and F). The phosphorylations’ level of Thr-758 of β2-chain varies between the 
SDF-1α and anti-CD3 activated T cells. The reasons behind this variation might be 
the difference among the key players involved in the signaling pathways. SDF-1α 
binds its receptors on the T cells and activates PI3K and PLCβ, and the latter 
activates CalDAG, Rap1, RapL and PKC (Kinashi 2005). On the other hand, the 
activation of integrins through TCR includes Lck (Fagerholm et al. 2002), which 
phosphorylates Zap-70, and PLCγ (Kinashi 2005). However, both chemokine and 
TCR pathways activate PKC which leads the phosphorylation of Thr-758 on β2-
chain of LFA-1 (Gahmberg et al. 2014).  
We showed that phosphorylation of the αL-chain played a significant role in 
the interaction of proteins with the β-chain. The phosphorylation of Thr-758 of 
the β2-chain lead to an increase in the 14-3-3 binding and filamin release from the 
β2-tail (Grönholm et al. 2011). We found a significantly lower amount of 14-3-3, 
α-actinin and at the same time also significantly more filamin protein was pulled 
down with LFA-1 after SDF-1α stimulation of αL mutant-expressing Jurkat cells as 
compared to the wt. Talin interaction was reduced but not significantly. There 
were also less 14-3-3 and α-actinin protein pulled down with LFA-1 from the anti-
CD3 activated αL mutant-expressing Jurkat cells as compared to the wt cells (IV, 
fig. 2A and B). There were different amounts of protein binding was seen from the 
SDF-1α and anti-CD3 treated wt αL-expressing cells and the reason might be that 
the phosphorylation levels of Thr-758 also varies after the SDF-1α and anti-CD3 
treatment of the the cells. Thus, the phosphorylation of Ser-1140 is important for 
the phosphorylation of Thr-758 and protein-protein interactions with the LFA-1. 
Furthermore, we showed that 14-3-3, talin and α-actinin interact only with the β2-
chain and not at all with αL-chain, and phosphorylation of Thr-758 increases 14-
3-3, talin and α-actinin binding to the β-chain in Jurkat cells (IV, Fig. 2 C and D). 
Ultimately, it is obvious that both α- and β-chain phosphorylations are important 
for the function of LFA-1. The importance of the α-tail in the regulation of integrins 
has previously been shown (O’Toole et al. 1994, Hughes et al. 1995). The proximal 
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membrane sites of both α and β-chains are α-helical and linked to each other. Rap1 
is reported to be an activator of LFA-1 by TCR activation or CXCR4 activation 
(Lagarrigue et al. 2016, Calderwood 2015). RapL binds to a site consisting of two 
Lys residues following the GFFKR motif in the αL-chain (Tohyama et al. 2003). 
Mutations of these two Lys to Ala inhibited the RapL binding and resulted in 
inactivation of integrin and ICAM-1 interaction (Tohyama et al. 2003). Binding of 
talin to the β2-chain also activates the integrins (Lagarrigue et al. 2016). Binding 
of the talin head inhibited the association of the proximal membrane site and 
pushed cytoplasmic tails of the α and β-chains apart from each other and activated 
LFA-1 (Vinogradova et al. 2004). The distal membrane regions vary in sequences 
and length, and their functions are less clear in integrin activation. It has been 
shown that in the case of α-chains, mutation or deletion in the distal membrane 
part of some α-chains affect integrin activation and adhesion to their ligands. For 
example, mutation of Ser-1158 to Ala in the αX chain in myeloid cells affects β2-
integrin mediated adhesion to the ligand iC3b (Uotila et al. 2013), and deletion of 
the α6’s distal part of the cytoplasmic tail abolished α6β1 integrin mediated 
adhesion to laminin. However, mutation of Ser-1064 and -1071 to Ala in α6-tail 
did not affect adhesion (Shaw & Mercurio 1993). This indicates that there may be 
different regulatory mechanisms at the membrane distal-parts among different 
integrins. Another study showed that deletion of the αL-membrane distal region 
inhibited talin- and kindlin-mediated integrin activation and ligand binding (Liu 
et al. 2015). NMR studies (Bhunia et al. 2009) showed that the αL cytoplasmic tail 
forms a triple-helical structure, i.e. involving helices 1, 2 and 3. Helix 1 is shorter 
and helix 3 is longest. Helix 3 is connected both with helices 1 and 2, and also both 
helices 1 and 3 are in connection with the β2-tail. Bhunia and colleagues also 
showed that Ser-1140 is located in the negatively charged helix 3 position of the 
αL-tail, and phosphorylation of Ser-1140 further enhances the negative charge of 
this surface. They proposed that the phosphorylation of Thr-758 allowed 14-3-3 
docking in the β2-chain in such a way the activation of LFA-1 is maintained 
(Bhunia et al. 2009) . We also showed that the negative charge in the αL 1140 
position, which resembled the phosphorylation of Ser-1140, was enough to 
enhance α-actinin binding. COS-7 cells have been used for functional studies of the 
integrins before (Larson et al. 1990) and it has also been shown that the 
phosphorylation of the αL-chain of Ser-1140 in COS-7 takes place (Fagerholm et 
al. 2005). We tranfected COS-7 cells to express active LFA-1 on the surface. First, 
we activated COS-7 cells by PMA since COS cells lack chemokine and TCR receptors. 
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The activation by PMA increased the phosphorylation of Thr-758 and 14-3-3 and 
α-actinin interactions with the β2-chain. We transfected αL Ser1140Ala and 
Ser1140Asp in combination with the wt β2-chain in COS-7 cells. We found strong 
α-actinin binding and phosphorylation of both αL Ser-1140 and β2 Thr-758 of 
LFA-1 after PMA activation. Mutation of Thr-758 to Ala reduced the α-actinin 
interaction. Again, when the cells expressed Thr758Asp in β2 in combination with 
Ser1140Ala, there was no α-actinin binding. However α-actinin interaction with 
β2-chain was further increased when a negative charge was introduced in both 
the α- and β-chains (IV, fig. 3A, B, C, D and E). The results showed that 
phosphorylation or negative charges on both αL-Ser-1140 and β2-Thr-758 are 
vital for the regulation of the α-actinin interaction with the β2-chain of LFA-1.  
Phosphorylation of both the α- and β-chains are important for functionally 
active LFA-1. In our study, we showed that of Ser1140Ala mutation on the α-chain 
abrogates cell adhesion as well as directional migration. This may be due to the lack 
of an adequate bridge between the integrin and the cytoskeleton because of the loss 
of α-actinin interaction with the β2-chain. We showed that the adhesion of 
Jβ2.7/LFA-1 αL mutant-expressing cells to the ligand ICAM-1 was significantly less 
as compared to the Jβ2.7/LFA-1 wt αL-expressing cells after both SDF-1α and anti-
CD3 activation (IV, fig. 1 D). Furthermore, we found that SDF-1α activated 
Jβ2.7/LFA-1 wt-expressing cells made long extensions on ICAM-1 and formed 
clusters on SDF-1α-coated wells, and these features of the cells were not seen in 
Jβ2.7/LFA-1 mutant-expressing cells (IV, fig. 1E). We performed adhesion complex 
isolation experiment, where we let the Jβ2.7/LFA-1 wt, and Jβ2.7/LFA-1 mutant 
adhere to the ICAM-1 coated plate after SDF-1α and anti-CD3 activation and purified 
adhesion complexes according to the protocol (Jones et al. 2015). As expected, we 
found α-actinin, 14-3-3, talin, and actin only in Jβ2.7/LFA-1 wt-expressing cells from 
SDF-1α-activated cells. Additionally, none of these proteins were found in the 
Jβ2.7/LFA-1 mutant-expressing cells. Instead, they were in the fraction of the 
unbound cells. It seems that SDF-1α is unable to activate the αL mutant Jurkat cells, 
and there is no active LFA-1 to make firm adhesion complexes with ICAM-1. On the 
other hand, in anti-CD3 activated cells less α-actinin, 14-3-3, and talin were found 
in the Jβ2.7/LFA-1 mutant-mediated adhesion complex with ICAM-1 compared to 
the wild-type. After these observations we concluded that Jβ2.7/LFA-1 αL mutant 
cells could be partially activated by anti-CD3 to bind ICAM-1, which was not the case 
for SDF-1α activation (IV, fig. 2 E, F, and G). The binding site of α-actinin resides in 
the β2-chain residues 736–746 (Sampath et al. 1998). α-actinin plays a vital role in 
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linking of the integrins to the cytoskeleton, which is essential for cell adhesion and 
migration (Otey & Carpen 2004). In our study we also studied cell adhesion by 
transfecting a peptide containing the α-actinin binding site of β2 in the Jβ2.7/LFA-1 
αL wt- expressing cells. This peptide blocked the interaction between α-actinin and 
the β2-chain. However, it did not affect talin’s interaction with the β-chain (Stanley 
et al. 2008). Static cell adhesion to ICAM-1 was inhibited by β2-peptide in 
Jβ2.7/LFA-1 αL wt cells activated with SDF-1α, but not by the control peptide (IV, 
fig. 5A). Jβ2.7/LFA-1 αL mutant-expressing cells with decreased α-actinin 
interaction also showed impaired cell migration towards a chemokine gradient. For 
this migration assay, we let the cells (both Jβ2.7/LFA-1 αL wt and mutant-
expressing, and both α-actinin binding site containing β2- and control peptide 
transfected in Jβ2.7/LFA-1 wt-expressing cells) migrate over an ICAM-1-coated 
chamber towards an SDF-1α gradient. We found that the directional migration 
towards the chemokine was impaired in the Jβ2.7/LFA-1 αL mutant cells and β2-
peptide transfected Jβ2.7/LFA-1 αL wt-expressed cells, which was not the case for 
either wt LFA-1 or control peptide transfected in Jβ2.7/LFA-1 wt cells (IV, fig. 5B). 
Lost or reduced of α-actinin interaction between the integrin and the cytoskeleton, 
turnover of adhesion and de-adhesion of cells decreased and directional migration 
was impaired. α-Actinin plays a vital role in linking the β2-integrins to the 
cytoskeleton, which is known to be essential for cell migration (Otey & Carpen 2004, 
Stanley et al. 2008a). It was shown that a conserved region (residues 733–742) in 
the β2-tail is critical for the cytoskeletal association (Pardi et al. 1995) and this 
region overlaps with the α-actinin interaction site (residues 736–746). Besides, a 
regulatory domain (residues 748–762) in the β2-chain inhibits the constitutive 
association between the β2-tail and α-actinin (Sampath et al. 1998). This regulatory 
domain also contains the Thr-758 phosphorylation site of the β2 chain. Thus, the 
phosphorylation of Ser-1140 on αL- and Thr-758 on β2-tail may influence the 
separation of the α- and β-tails from each other and facilitate the α-actinin binding 
by releasing the inhibitory structure. This results in the activation of the ligand 
binding domain of the integrin, as shown with the active epitope NKI-L16 antibody, 
and migration of the cells. The importance of α-chain phosphorylation for migration 
is also observed with the α4 integrin. Phosphorylation of Ser-988 is required for α4-
dependent migration and lamellipodia stability, and it blocks the binding of paxillin 
(Goldfinger et al. 2003, Han et al. 2003). The morphology of Jβ2.7/LFA-1 αL mutant 
cells was rounded and less polarized as compared to αL wt-expressing cells. In our 
migration assay, Jβ2.7/LFA-1 αL mutant cells were not able to move towards SDF-
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1α gradient. Instead, they ruffled in different directions, and the cell body remained 
in place. Stanley et al. 2008a observed that the cells lacking α-actinin adhered on 
ICAM-1 but were unable to translocate on the membrane. Furthermore, both the 
accumulated and euclidean distances, as well as directionality, were reduced in cells 
with impaired α-actinin–integrin binding (IV, fig. 4C, D, and E). These observations 




Integrins not only function as adhesion receptors, but also convey signals either 
from inside-out or outside-in to the cells, and induce cell migration upon chemokine 
stimulation. We now have a deeper understanding of integrin structure, integrin–
ligand interaction, cytoplasmic chain interacting proteins and their influence on 
cytoskeleton reorganization. Integrins are also vital for mechanotransduction and 
motility of the cells, and a knowledge of the role of integrins in the control of the 
tumor microenvironment is emerging (Longmate & DiPersio 2017). In my studies, I 
have elucidated the importance of the phosphorylation of Thr-758 on the β2-chain 
and Ser-1140 on the αL-chain of the LFA-1 concerning the regulation of the LFA-1 
signaling. I have identified a new key player, Tiam-1, in intracellular signaling 
downstream of LFA-1. Tiam1 forms a complex with pThr-758 of the β2-chain and 
14-3-3, which activates Rac1. I have explained the crosstalk mechanisms of the 
activation of LFA-1 to the VLA-4. The regulation of the VLA-4-mediated adhesion to 
VCAM-1 is controlled through the phosphorylation of the Thr-758 on the β2-chain 
of LFA-1(Figure 16). I have shown that the phosphorylation of the Ser-1140 of αL-
chain is significant for the functionally important phosphorylation of Thr-758 on the 
β2-chain. Phosphorylation of Ser-1140 is important for the interaction of LFA-1 
with cytoplasmic proteins although the binding sites for these proteins reside in the 
β-chain (Figure 17).  
Because of the ability of the integrins to regulate cell adhesion, migration 
and protein-protein interactions, they are potential therapeutic targets. The 
specificity of phosphorylation or ligand interaction are distinctive features of 
specific integrins, even between members of the same family of integrin. Although 
we have revealed some of the important and novels mechanisms for the regulation 
of the leukocyte integrins, certainly a large number of questions remains 
unanswered and new ones are emerging, which require more experiments to 
answer. For example, we do not know which kinases are responsible for the α-
chain phosphorylation of β2-integrins. Another exciting phenomenon is that the 
transdominant inhibition of VLA-4 by activated LFA-1. The transdominant 
inhibition between VLA-4 and β2-integrins could be targeted for the inhibition of 
autoimmune diseases, such as MS. 
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Schematic conclusions of the research 
 
Figure 16: Activation of LFA-1 through TCR or CXCR4 or by antibodies against LFA-1, causes 
the phosphorylation of PLC, which activates PKC to phosphorylate Thr-758 of the β2-chain 
and turns LFA-1 into the active conformation. Active LFA-1 releases filamin from the β2-
chain, 14-3-3 binds to the phosphorylated β2, and Tiam1 makes a complex with 14-3-3, 
activating Rac1. Activate LFA-1 also induced dephosphorylation of Thr-788/789 of the β1-
chain of VLA-4 inactivating VLA-4. 14-3-3 is released from the cytoplasmic tail of the VLA-4, 




Figure 17: The chemokine SDF-1α cannot activate the LFA-1 when there is a mutation in the 
αL-chain at Ser-1140. When wt LFA-1 is activated by SDF-1α, it phosphorylates Thr-758 of 
the β2-chain, which facilitates the binding of α-actinin and 14-3-3. On the other hand, a 
mutation in Ser-1140 to Ala in the αL chain inhibits Thr-758 β2 phosphorylation and further 
α-actinin and 14-3-3 binding to LFA-1, which as a result cannot open the activation epitope 
for ligand binding. 
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